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 1
GENERAL INTRODUCTION 
 
Organic chemistry has served as a solid foundation for interdisciplinary research 
areas, such as molecular biology and medicinal chemistry.  An understanding of the 
biological activities and structural elucidations of natural products can lead to the 
development of clinically valuable therapeutic options.  The advancements of modern 
synthetic methodologies allow for more elaborate and concise natural product syntheses.   
The theme of this study centers on the synthesis of natural products with particularly 
challenging structures and interesting biological activities.  The synthetic expertise developed 
here will be applicable to analog syntheses and to other research problems. 
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CHAPTER 1. SYNTHESIS OF PAPUAFORIN B AND RELATED 
PHLOROGLUCINOL NATURAL PRODUCTS 
 
Introduction 
An understanding of the biological activities and effects of herbal supplements 
becomes essential for efficacy and safety concerns with the increasing use of dietary 
supplements.  Recently, the antidepressant activity of Hypericum perforatum, commonly 
known as St. John’s wort, has drawn much attention.1-4  St. John’s wort is commonly used as 
a natural remedy to treat moderate to mild depression.  Studies of the constituents of St. 
John’s wort and other plants from the family Guttiferae have disclosed a class of compounds, 
polycyclic polyprenylated acylphloroglucinols (PPAPs), with fascinating structures and 
interesting biological activities.  
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Figure 1.  Polycyclic polyprenylated acylphloroglucinol (PPAP) natural products 
 
Hyperforin (1) was first isolated in 1971 from the species Hypericum perforatum,5 
and has drawn substantial attention, because it is thought to be responsible for the 
antidepressant and antibacterial activities of St. John’s wort.6-10  Its antidepressant activity is 
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attributed to a broad inhibitory effect on the synaptosomal uptake of several 
neurotransmitters, such as serotonin, noradrenaline, dopamine, γ-aminobutyric acid (GABA) 
and L-glutamate at hyperforin concentrations as low as IC50 = 1.1 μg/mL.11  A recent report 
has shown that hyperforin (1) inhibits penicillin-resistant and methicillin-resistant 
Staphylococcus aureus, which is resistant to various antibiotics, such as the cephalosporins, 
erythromycin and  clindamycin.12   
Nemorosone (2) is the major constituent of Clusia (Clusiaceae) species resin,13 and is 
known to possess antimicrobial, cytotoxicity and antioxidant activities.14-16  Garsubellin A 
(3) was isolated from the wood of Garcinia subelliptica (Guttiferae) in 1997.17  Garsubellin 
A (3) enhances choline acetyltransferase (ChAT) activity in P10 rat septal neurons relative to 
a control by 154% at a 10 μM concentration.18  Choline acetyltransferase (ChAT) is involved 
in the biosynthesis of neurotransmitter acetylcholine (ACh) in the nervous system.  Taking 
into account that Alzheimer’s disease has been attributed to deficiencies in the levels of 
acetylcholine (ACh),19  The ChAT enhancing activity of garsubellin A (3) provides potential 
in developing chemotherapies for Alzheimer’s disease.  Papuaforin B (4) is extracted from 
Hypericum papuanum (Papua New Guinea).  Its chemical structure is similar to hyperforin 
(1) with the additional 2,2-dimethyl-2H-pyran ring that is probably formed by cyclization of 
a 3-methylbut-2-enyl side chain with an enolic hydroxyl group. 
The biosynthesis of hyperforin (1) was proposed using early labeling experiments, 
which involve acylphloroglucinols and isoprenoid moieties (Figure 2).20  The 
acylphloroglucinol moiety is generated by a polyketide type biosynthesis beginning with two 
units of pyruvate. Condensation of malonyl-CoA and acyl-CoA furnishs a tetraketide, which 
undergoes cyclization to acylphloroglucinol 5.  Enzyme-catalyzed prenylation of 5 using 
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prenyl pyrophosphate, derived from a non-mevalonate pathway, generates 6 which, upon 
prenylation and cyclization, would provide hyperforin (1). 
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Figure 2.  Proposed biosynthesis of Hyperforin (1) 
 
In the past decade, the significant biological activity and challenging structure of this 
class of natural products have drawn many synthetic chemists’ attention.  However, most 
studies rely only on the construction of the bicyclic core structure, not surprisingly, because 
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of its synthetically formidable structural features.  Indeed, two total syntheses of garsubellin 
A (3) have been reported.21,22     
Nicolaou firstly reported a synthetic route to the highly functionalized core structure 
of garsubellin A (3) employing a selenocyclization approach.23  Initially, the requisite 
precursor 8 was synthesized from commercially available 1,3-cyclohexanedione in eight 
steps (Scheme 1).  The selenium-mediated cyclization in the presence of N-
(phenylseleno)phthalimide (N-PSP) and SnCl4 furnished the selenide 9.  Selective reduction 
of the bridged ketone of 9 produced a single alcohol, which, upon alkylation with trans-1,2-
bis(phenylsulfonyl)ethylene, yielded vinylogous sulfone 10.  The construction of tetracycle 
11 by the use of n-Bu3SnH and AIBN, followed by the sequence of reactions : reduction, 
selective monoprotection, and oxidation formed the corresponding aldehyde 12.  
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The use of isopropenylmagnesium bromide effected the addition to the aldehyde with 
concomitant β-elimination of the sulfone side chain.  Selective hydrogenation by using 
H2/PtO2 produced isopropyl alcohol 13 (Scheme 2).  Subsequently, selective protection of the 
two free hydroxyls of 13 as a cyclic carbonate, followed by hydrogenation, produced 
intermediate 14.  After oxidation of the free hydroxyl of 14, the ensuing conversion of the 
saturated ketone to an α,β-unsaturated enone was accomplished to give 15.  For completion 
of the bicyclic core, the regio- and stereoselective [2+2] cycloaddition was employed to give 
the protected cyclobutanone adduct 16.  Deprotection and subsequent Baeyer-Villiger 
oxidation completed construction of the fully functionalized bicyclic core (17) of garsubellin 
A (3).  
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Nicolaou’s strategy introduced several interesting synthetic steps, which include 
biomimetic electrophile-mediated cyclizations of a pendant prenyl group and a novel bicyclic 
cycloaddition.  However, the many steps to the core structure of garsubellin A (3) might limit 
its practical use towards this class of natural products syntheses.  
In 2005, Shibasaki first reported the complete total synthesis of Garsubellin A (3).21  
The Shibasaki synthesis began with commercially available 3-ethoxycyclohex-2-enone, 
which underwent prenylation, methylation, and acid hydrolysis of the vinyl ether to yield an 
enone (Scheme 3).  
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Scheme 3 
 
Conjugate addition of an methyl cuprate and in situ trapping of the resulting 
magnesium enolate by isobutyraldehyde gave the anti-aldol product, which was protected by  
TIPS to give 18.  Protection of the prenyl group, followed by addition of an additional prenyl 
group, gave 19. Attempted aldol reaction with acetaldehyde occurred at the sterically less 
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demanding α-carbonyl position, which was then dehydrated to the corresponding olefin 20 
using the Martin sulfurane.  Highly chemoselective dihydroxylation and protection of the 
diol furnished carbonate 21.  Cyclization precursor 22 was generated in four straightforward 
steps from 21: desilylation, oxidation, O-allylation and stereoselective Claisen rearrangement.  
A ring-closing metathesis reaction of 22 was realized by employing the Hoveyda-Grubbs 
catalyst24 to construct the crucial bicyclic skeleton of 23 (Scheme 4).  
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Scheme 4 
 
Allylic oxidation, and subsequent deprotection of the MOM ether using CSA 
provided the alcohol 24.  Upon hydrolysis of the carbonate, the secondary alcohol underwent 
Wacker oxidative cyclization to give 25.  In order to secure two prenyl groups, 25 was 
further functionalized to a vinylic iodide, which was then dehydrated to regenerate the prenyl 
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group. The total synthesis of garsubellin A (3) was completed by Stille coupling of 26 with 
tributylprenyltin. 
Shibasaki’s group completed the total synthesis of the target compound by a 
reasonably direct synthetic route, except for the low yield of the final step. They also 
mentioned that this synthesis could be extended to an asymmetric synthesis of garsubellin A 
(3) by early introduction of a catalytic, enantioselective alkylation method developed by 
Koga.25   
A recent report from Danishefsky’s group described the complete synthetic effort to 
garsubellin A (3).  It involved a unique synthetic approach.22   For the construction of the 
bicyclic skeleton, they dearomatized a substituted phloroglucinol, a step reminiscent of  the 
biosynthetic pathway to hyperforin (1).  
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The synthesis commenced with regioselective prenylation of the protected 
phloroglucinol derivative (Scheme 5).  Dihydroxylation of 27, followed by acetonide 
formation and desilylation using TBAF, gave phenol 28.  The product 29 was obtained by 
allylation of 28, either by direct allylation at the para carbon or by O-allylation, followed in 
sequence by rapid o-Claisen and Cope-like rearrangements.  Upon treatment with  aqueous 
acid, the acetonide group of 29 was removed, and ensuing conjugate addition and hydrolysis 
provided 30 as a single diasteromer.  An olefin cross metathesis reaction converted the allyl 
group into a prenyl group.  Iodocarbocyclization led to 31, which contained the key 
bicyclo[3.3.1]nonane ring system. 
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Vinylic iodination of 31 using the iodine/CAN system gave triiodinated compound 32.  
Metal-halogen exchange using excess isopropylmagnesium chloride with careful temperature 
control promoted a transannular Wurtz cyclopropanation reaction.  Upon allylation of the 
remaining vinylic Grignard intermediate, 33 was produced, which was then successfully 
returned to the bicyclo[3.3.1]nonane skeleton by treatment with TMSI.  Allyltributyltin-
mediated radical allylation introduced an allyl group to the sterically favored exo face.  The 
product was subjected to cross metathesis reactions to install two prenyl moieties. 
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Disilylation of both the tertiary alcohol and bridgehead carbon positions of 35, followed by 
iodination, provided 36.  Metal-halogen exchange and subsequent treatment with 
isobutyraldehyde yielded adduct 37.  Oxidation and deprotection of the TMS ether completed 
the synthesis of garsubellin A (3). 
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Danishefsky’s synthetic route is direct and efficient, and employed a biomimetic 
approach in the initial stage.  However, given the modest and variable yields of some steps, 
there is room for improvement.  Keeping in mind that this class of natural products contains 
the bicyclic acyl phloroglucin subunit, the main focus of this study will be placed on finding 
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an efficient route for the construction of the fully elaborated bicyclo[3.3.1]nonane skeleton, 
and also its successful application to their total synthesis. 
 
Results and Discussion 
The synthetically challenging structure and diverse biological activities of the 
phloroglucinol-containing natural products prompted a synthetic study to establish a general 
strategy towards the bicyclic core.  This could lead to a total synthesis of this natural product 
(Figure 3). 
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Figure 3.  Bicyclic core structure of PPAPs 
 
Our initial approach commenced with the Michael addition26 of ethyl 2-
cyclohexanone carboxylate with acrolein using a catalytic amount of sodium ethoxide to 
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produce aldehyde 38 (Scheme 8).  Intramolecular aldol condensation of aldehyde 38 to 
produce alcohol 39 under acidic conditions, followed by oxidation of 39 with pyridinium 
chlorochromate, produced ketone 40 (72% overall yield from ethyl 2-cyclohexanone 
carboxylate).   
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Scheme 8 
 
With ketone 40 in hand, the conversion to enone 41 was achieved using conditions 
developed by Larock and Kraus27 (Scheme 9).  After several attempts, we found an efficient 
way to construct the enolic bicyclic β-diketone 45 from the key intermediate 41 as depicted 
in Scheme 9. 
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Scheme 9 
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Although this result for the funtionalized bicyclo[3.3.1]nonane synthesis was 
successful, we found some limitations of this synthetic strategy for its practical application 
towards the more elaborated bicyclic core.  According to our preliminary studies, as shown in 
Scheme 10, the Michael addition of acrolein onto the cyclohexanone carboxylate 46 yielded 
no desired product.  This presumably resulted from the steric hindrance of the geminal 
dimethyl group of the enolate.  The protocol employing the conjugate addition of 
benzenethiol to the bicyclic enone 41 required a multistep route to produce the desired β-
diketone 45 (Scheme 9).  Furthermore, benzenethiol did not react with 48 (Scheme 10).  
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Scheme 10 
 
The synthetic challenge of establishing the bicyclic skeleton in a sterically demanding 
environment prompted us to find a better synthetic route to overcome these problems.  Our 
second approach to the target molecule relied on the construction of the bicyclic β-diketone 
compound via cyclization, followed by oxidation, as shown in the retrosynthetic analysis 
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(Figure 4).  After the functionalized bicyclic core is constructed, the β-diketone would be 
constructed to obtain the target molecule. 
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Figure 4.  Retrosynthetic analysis 
 
In the course of a program directed towards a suceessful route for the synthesis of the 
bicyclic core unit, manganese(III)-mediated oxidative radical cyclizations caught our 
attention.  This methodology has been extensively investigated by Snider and co-workers.28  
It requires an alkene moiety to form a bicyclic frame.  The allyl-substituted starting 
compound may be readily accessible (Scheme 11).  
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Scheme 11.  The oxidative free-radical cyclization mechanism 
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Manganese(III)-mediated oxidative radical cyclization provides additional benefits.  
First, the reaction is quite general.  Second, it might enable the construction of the bicyclic 
structure with a handle for introducing the β-diketone functionality.  
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Our synthetic route began with the known 2-benzoylcyclohexanone (50), since the 
benzoyl group in compound 50 is present in the natural product nemosorone (2) (Scheme 12).  
Alkylation with allyl bromide and sodium hydride at an elevated temperature yielded 
allylated compound 51 in 60% yield.  With this compound, cyclization using manganic 
triacetate and cupric acetate according to the method of Snider gave a 76% isolation yield of 
the desired diketone 52 and a trace amount of the exo-cyclization by-product. 
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Cyclized product 52 was then oxidized using PDC/t-BuO2H to generate enone 53 
(Scheme 13), a key intermediate for introducing the β-diketone.  However, efforts to induce 
bicyclic β-diketone  under a variety of reaction conditions were not successful. 
In order to minimize the number of synthetic steps and increase the reactivity of the 
bicyclic enone, generation of β-halo enone 56 was attempted (Figure 5).  The presence of a 
good leaving group would increase the electrophilicity of enone 56, thus making it more 
susceptible to conjugate addition.  In essence, the β-bromo enone’s electrophilicity would be 
comparable to an acid chloride.  The retrosynthetic analysis depicted in Figure 5 indicates 
that the β-diketone 55 could be made from β-bromo enone 56, which could be made from the 
bicyclic alkene 57.  Employing the synthetic strategy, the key step would be the 
transformation of the bicyclic olefin 57 to the corresponding β-halo enone 56, since, to our 
knowledge, there is no literature precedent for the direct construction of β-bromo enones 
from disubstituted olefins.  
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Figure 5.  Retrosynthetic Analysis 
 
Our synthetic study commenced with previously prepared bicyclic compound 52 
(Scheme 13).  Epoxidation of 52 using MCPBA in methylene chloride produced epoxide 59 
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in an 80% yield.  Attempts to transform epoxide 59 to allylic alcohol 60 failed using several 
epoxide opening conditions, such as LDA, Al(O-i-Pr)3, (PhSe)2/NaBH4, DBN/TMSI, 
DBU/TMSI and DIEA/TMSI. 
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Instead of using the unexpectedly stable epoxide 59, we decided to introduce bromine 
onto the bicyclic compound 52.  An NBS/AIBN-mediated bromination of compound 52 
generated the desired allylic bromo compound 61 in good yield.  Upon treatment of 
compound 61 with excess bromine, dibromo compound 62 was produced in moderate yield.  
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Attempted epoxidation of dibromide 62 by MCPBA failed (Scheme 16).  Based on 1H 
NMR spectral analysis, it produced a complex mixture with mostly unreacted 62.  We were 
pleased to find that treatment of 52 with 3.3 equivalents of NBS and a catalytic amount of 
AIBN gave a mixture of enone 64 and tribromide 65 in a 73% combined yield (Scheme 17).  
Tribromide 65, a precursor to 64, was readily converted into 64 upon treatment with hot 
aqueous acetic acid.  The transformation of diketone 50 to enone 64 was achieved in only 
three steps with a 33% overall yield. 
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Scheme 17 
 
We believe that compound 52 may undergo tribrominations in the presence of excess 
NBS, which was then hydrolyzed leading to 64. 
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Scheme 18. Plausible mechanism to β-bromo enone 64 
 
Displacement of β-bromoenone 64 using sodium allyloxide provided 67, which was 
then heated in a sealed tube at 170 °C to afford tetraketone 68 via a Claisen rearrangement 
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(Scheme 19). The structure assignment of 68 was supported by 1H and 13C NMR, IR and 
high resolution mass spectrometry. 
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The synthesis of 68 in good overall yield constitutes a useful preparation of analogs 
of nemorosonone (2).  The synthetic route is direct and flexible enough to be extended to a 
synthesis of natural products, such as hyperforin (1) and its analogues. 
The next objective was the preparation of a more advanced intermediate bearing a 
geminal dimethyl group at C3.  The diketone 73 was synthesized based on Rothberg’s 
protocol in his synthesis of dehydroambliol-A.29  The synthesis began with condensation of 
6-methyl-5-hepten-2-one and methyl benzoate to produce diketone 70 (Scheme 20).  The 
Lewis acid-catalyzed cyclization of 70 afforded 71.  Treatment of 71 with sodium hydride 
and allyl bromide at boiling temperature yielded O-allylated product 71 in good yield.  
Heating at 180 °C in a sealed tube gave the rearranged compound 73. 
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Scheme 20 
 
Contrary to our expectation, the reaction of 73 with Mn(OAc)3/Cu(OAc)2 in acetic 
acid at 90 oC exclusively afforded compound 75.  We did not find any evidence for the 
formation of 74 (Scheme 20).  Although the exclusive formation of 75 could not be explained, 
it is conceivable that the more favorable conformation of the α-carbonyl radical could be 73b, 
which positions the benzoyl group in an axial position.  This conformation appeared to have 
less steric interaction with the geminal dimethyl group (Scheme 21).  
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Scheme 21 
 
After ortho attack of the α-carbonyl radical on the benzoyl group, the resonance-
stabilized α-keto radical adduct 73c is generated.  It is then oxidized by Cu(II), and readily 
undergoes aromatization to form diketone 75. 
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To circumvent the problems associated with the conformational issues, oxidative 
radical cyclizations using regioisomers of diketone 73, such as 76 or diallylic diketone 77, 
were examined (Scheme 23).  LDA-mediated enolation and subsequent dianion formation by 
adding n-butyllithium at 0 oC, followed by treatment with allyl bromide, furnished diketone 
76 in a 56% yield.  Diallylation product 77 was also obtained in 50% yield by repeating the 
same conditions.  Unfortunately, attempted manganic triacetate-mediated oxidative 
cyclizations failed.  Neither 76, nor 77, gave the desired cyclized products.  Only starting 
compounds were recovered.   
 
O O
Ph
LDA, n-BuLi, 0 oC
then, allyl bromide
O O
Ph
Mn(OAc)3
Cu(OAc)2
AcOH, 80 oC O
COPh
71 76
78
LDA, n-BuLi, 0 oC
O O
Ph
77
then, allyl bromide
R
 
 
Scheme 23 
 
In 1980, Ley and co-workers30 reported a selenium-mediated cyclization reaction 
(Scheme 24).  This protocol interested us as another cyclization method for our system.  The 
reaction furnished oxygen-cyclization compound 80.   Intramolecular rearrangement of 80 
under Lewis acid conditions gave the corresponding carbon-cyclized counterpart 81, which 
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seemed particularly interesting, since oxidative elimination of the phenylselenyl group in 81 
may provide a bicyclo[3.3.1]nonene unit, a precursor for our key bromination reaction. 
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To investigate the applicability of Ley’s protocol to our system, compound 71 was 
first methylated via the dianion.  Subsequent allylation by the same method yielded 84.  
Compound 84 was treated with PhSePF6 at -78 oC and then slowly warmed to room 
temperature to afford selenide 85 in a 70% yield.  
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Unfortunately, the attempted carbon-carbon bond forming reactions by the 
rearrangement of selenide 85 in the presence of SnCl4 were not successful.  The reactions 
either went back to 84 or remained as 85. As this disappointing result might be related with 
the decreased reactivity of the diketone with respect to the approaching electrophile due to 
the strong steric demand of the geminal dimethyl group, it was felt that the oxidative radical 
cyclization conditions [Mn(OAc)3/Cu(OAc)2] might solve this problem.  First, the 
installation of an allyl group onto the sterically hindered system proceeds with ease. Second, 
aromatic radical cyclizations could be avoidable by changing the benzoyl group to an ester.  
Recall that PPAPs contain isobutyryl or benzoyl groups at the bridgehead carbon.  The ester 
group could be easily converted either into isobutyryl or benzoyl group.  
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The starting material was the known keto ester 90 that was conveniently prepared 
following Rothberg’s account.29 With this keto ester 90 in hand, the manganic triacetate 
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oxidative cyclization was then examined.  To our delight, 91 was obtained without difficulty 
under the reaction conditions outlined in Scheme 26. Bromination of 91 with 3.5 equiv. of 
NBS in the presence of molecular sieves directly afforded β-bromoenone 92 in a 55% yield 
(Scheme 27).  In this case, no evidence was found for the tribromide.  The 13C NMR 
spectrum supported the production of one regioisomer.  The structure for 92 was assigned 
based on a comparison of the chemical shift of the bridgehead hydrogen in 92 with that of the 
bridgehead hydrogen in a model system.31  Substitution of bromide 92 with sodium 
allyloxide, followed by a Claisen rearrangement at 140 oC, produced tetraketone 93. 
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A concise synthesis of the functionalized bicyclic core subunit of acyl phloroglucinol 
natural products was achieved in eight steps.  In the above sequence of events leading to 93, 
the bromination-hydrolysis methodology served the crucial role to transform bicyclic olefins 
into bicyclic β-diketones.  At this point, we must point out that access to the natural products 
required the extension of this chemistry to more substituted compounds, since this class of 
natural products contains either a prenyl or a methyl group on the bridgehead position as 
illustrated in Figure 3. 
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Based on our success, we focused on the application of this synthetic sequence to 
more heavily substituted compounds bearing two quaternary centers.  This will provide a 
bicyclo[3.3.1]nonane ring system with much closer structural analogy to the natural products.  
The synthesis started from previously prepared diketone 88 (Scheme 28).  Treatment 
of diketone 88 with LDA, followed by n-butyllithium at 0 oC, gave a dianionic intermediate, 
which was quenched by iodomethane to give the corresponding diketone 94 in a 61% yield.  
Allylation using NaH and allyl bromide generated O-allylated compound 95, which then 
underwent thermal rearrangements to the desired C-allylation compound 96 in a 54% yield. 
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Scheme 28 
 
Intramolecular cyclization of compound 96 was attempted by the use of manganic 
triacetate and cupric acetate in acetic acid at 80 oC as demonstrated in the Snider protocol.28  
Unfortunately, it failed to yield the bicyclo[3.3.1]nonane skeleton 97. Instead, starting 
compounds were recovered.  
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In the course of searching for an alternative method to construct the 
bicyclo[3.3.1]nonane skeletal framework, we found that Padwa had developed innovative 
methodology using sulfones as Michael acceptors (Scheme 30).32     
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Scheme 30 
More interestingly, Anzeveno and co-workers33 have reported α,α’-annelation of 
cyclic ketones using 3-chloro-2-phenylsulfonyl-1-propene as a Michael acceptor.  It is 
noteworthy that it forms the bicyclic skeleton in good yield in one step by treatment of an 
enamine with a vinylic sulfone (Scheme 31).  It was envisioned that this vinylic sulfone 
could permit construction of the functionalized bicyclic skeleton even in a sterically 
congested system.  Based on our literature studies, we applied this chemistry to our 
cyclization step using 3-chloro-2-phenylsulfonyl-1-propene as Michael acceptor.  
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Instead of using enamines as a nucleophile, keto esters 88 and 94 were used, because 
enamine formation could not be realized from α,α’-disubstituted ketones.  Gratifyingly, the 
Michael addition of diketone 88 onto sulfone 107 in the presence of one equivalent of 
sodium hydride afforded vinylic sulfone 102 in a 60% yield (Scheme 32).  
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The sulfone 107 seemed to be a more reactive Michael acceptor than acrolein to 
overcome the steric hindrance of the geminal dimethyl group.  Attempted Michael addition 
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of acrolein with diketone 46 failed.  Michael addition of 107 onto the α-methylated keto ester 
94 proceeded smoothly to afford 103 in good yield.  However, cyclization of 102 with a 
strong base, such as potassium tert-butoxide, was unsuccessful.  Further oxidation of 
compound 103 to epoxide 104, followed by potassium tert-butoxide addition at 0 oC afforded 
O-cyclized product 106. 
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Subjecting 88 to one equivalent of sodium hydride, followed by treatment with 107 
and extending the reaction time to 16 hours at room temperature, produced a small portion of 
the desired bicyclic sulfone 109, together with the major sulfone 102 in 64% combined yields. 
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Although 109 was a minor product, it was envisaged that optimization of the 
conditions might lead to the bicyclic sulfone 109 in one pot or, at least, enhance the product 
ratio.  Surprisingly enough, the use of two equivalents of sulfone 107 and two equivalents of 
sodium hydride at room temperature gave bicyclic sulfone 109 in good yield as the exclusive 
product(Scheme 34).  This reaction was also successful for the α-methylated diketone 94, 
which afforded bicyclic sulfone 110 in a 54% yield.  
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The next task was conversion of sulfone 110 to the corresponding olefin 112 (Scheme 
35).  Our initial approach was the base-assisted elimination of sulfones, where the sulfone 
group acts as a leaving group, since sulfinates are well-known leaving groups.34 
Unfortunately, an attempted elimination reaction using DBU at 200 oC failed.  Further efforts 
to produce compound 112 by conversion of sulfone 110 into vinylic sulfone 113 or sulfoxide 
111 under a variety of different conditions were also unsuccessful.  Taking into account the 
low basicity of sulfones compared to sulfoxides and the sterically congested bicyclic domain, 
the unsuccessful outcomes resulted from either fuctional group interconversions or 
unexpected heat-assisted desufonylations.  
With these disappointing results, we prepared a series of Michael acceptors based on 
sulfone 107, which could lead to compound 112 from either pathway A or B (Scheme 36).  
The synthesis of compound 110 would be realized via pathway A where sulfoxide 114 is 
employed.  Sulfoxide 110 could act as a leaving group to afford alkene 112.  It is known that 
the proton affinity of dimethyl sulfoxide is 17 kcal/mol more than that of dimethyl sulfone.35 
Pathway B describes an alternative approach to 112 employing various sulfone derivatives 
115-118 with the idea of performing two successive Michael additions to form a bridged 
bicyclic system.  Reductive elimination of the sulfone moiety and subsequent liberation of 
leaving groups (X-, MeO-, AcO-, etc.) will give alkene 112.  
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Scheme 36 
 
After several screening tests for addition reactions of keto ester 94 and Michael 
acceptors 114-118, diacetoxy sulfone 118 showed the most promising results.  The synthesis 
of 118 began with commercially available 3,3-diacetoxypropene. Addition of phenylsulfenyl 
chloride followed by oxidation of the sulfide with 2 equiv of MCPBA, gave sulfone 120. 
DBU-mediated dehydrochlorination of 120 was unsuccessful.  It produced a complex 
mixture. However, the use of diisopropylethylamine (DIPEA) as a substitute for DBU, 
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sulfone 118 was obtained as the exclusive product.  The synthesis of 118 was accomplished 
in an 80% overall yield on a 50 mmol scale (Scheme 37). 
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At first, the attempted Michael addition of diketone 94 with sulfone 118 in the 
presence of two equivalents of sodium hydride in THF at 25 oC failed to give the addition 
product 121. However, reaction of 94 with exactly one equivalent of sodium hydride, 
followed by the addition of sulfone 118, furnished a 71% isolated yield of adduct 121 as one 
diastereomer based on proton NMR spectral analysis (Scheme 38).  Excess sodium hydride 
seems to promote the decomposition of sulfone 118 before it participates in the addition 
reaction. The stereochemistry of the methyl group relative to the quaternary center was not 
established. Once it forms the bicycle[3.3.1]nonane skeleton, the relative stereochemistry of 
the methyl group would be established.  The E-stereochemistry of β-acetoxy sulfone 121 was 
determined by a NOESY experiment. 
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Scheme 38 
 
Similarly, Michael addition reactions to generate β-acetoxy sulfone adducts were also 
examined to extend and generalize the applicability of 118 to various keto esters (Table 1). 
Overall reaction yields were good to excellent (70 ~ 100%) as shown in Table 1.  In the case 
of less sterically hindered cyclic keto esters (Table 1, entries 3-6), excellent yields of Michael 
addition products were obtained.  An acyclic keto ester (Table 1, entry 7) also furnished a 
70% isolated yield of adduct.  
Cyclization of keto sulfone 121 using one equiv of potassium tert-butoxide at ambient 
temperature produced three products, esters 122, 123 and 124 in 20%, 5% and 50% yields, 
respectively (Scheme 39).  The product 122 was derived from the deacetylation of 123. In 
order to enhance the yield of the cyclization products, 121 was converted to pivalate 125 in 
80% yield using potassium tert-butoxide and pivaloyl chloride at 0 oC. 
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Table 1. Michael addition reactions of 3,3-diacetoxy-2- 
(phenylsulfonyl)propene and β-keto esters 
O
OMe
O
O
OMe
O
SO2Ph
NaH, THF, rt
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O
O
O O
O
O
SO2Ph
entry product yield (%)
1 71a
O
OMe
O
O
OMe
O
SO2Ph
2 70a
O
OEt
O
O
OEt
O
SO2Ph
3 100
O
OEt
O
O
OEt
O
SO2Ph
6 100
O
OEt
O
O
OEt
O
SO2Ph
7 75
aAfter the addition of the sulfone, Ac2O (1 equiv.) was added. bUpon completion of 
the sulfonylations, t-BuOK (3 equiv.) was added at 0 oC, followed by addition of 
pivaloyl chloride (3equiv.).
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O
O
OMe
O
SO2Ph
5 91
O
OEt
O
O
OEt
O
SO2Ph
4 75b
AcO
OAc
AcO
AcO
AcO
AcO
AcO
AcO
PvO
AcO
SO2Ph
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Reaction of 125 with potassium tert-butoxide in THF from 0 oC to room temperature 
afforded a 56% isolated yield of 126 as a 1.3:1 mixture of diastereomers. 
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Scheme 39 
 
Base-promoted cyclization of 127 also proved problematic due to the instability 
associated with the labile acetoxy group under basic conditions.  Initially, sulfone 127 was 
converted into tosylate 128 using potassium tert-butoxide and para-toluenesulfonyl chloride 
at 0 oC.  Cyclization of 128 with potassium tert-butoxide afforded 131 in a 90% yield.  After 
the transformation of sulfone 127 to 129, pivalate 129 was cyclized to 130 (single 
diastereomer based on proton NMR spectroscopy) in a 57% yield using KH in THF at 0 oC 
(Scheme 40).  
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In view of the problems with acetate 121 and tosylate 127, sulfones 132 and 134 were 
converted to the corresponding pivalates, which were then exposed to the cyclization 
conditions using potassium hydride.  Both systems cyclized, producing adducts 133 and 135 
in 40% and 83% yields, respectively.  
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The formation of 135 was an unexpected result.  The reaction of the pivalate derived 
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from 134 with potassium hydride might first undergo a rather unusual hydride addition to the 
enone system, which subsequently cyclized to generate pivalate 135.  The reaction proceeded 
very cleanly with generation of 135 in an 83% yield as a single diastereomer based on proton 
NMR analysis (Scheme 42).  
 
O
SO2Ph
PivO
O
SO2Ph
135
PivO
CO2Me
CO2Me
134KH
OK
SO2Ph
AcO
CO2Me
135a
H
a
b
a b
OK
SO2Ph
PivO
CO2Me
134b
H
O
S
PivO
CO2Me
O OK
Ph
134c
single diastereomer  
 
Scheme 42 
 
Acetoxy sulfone 136, obtained from alcohol 126 in a 95% yield by acetylation with 
acetic anhydride and DMAP in methylene chloride at 25 oC, was converted into the alkene 
112 using sodium amalgam36 in MeOH in 57% yield.   Product 112 contained alkyl and acyl 
functions at bridgehead carbons, a pattern seen in phloroglucinol natural products.  
Interestingly, pivalate 135 provided only desulfonated product 137 (Scheme 43).  We did not 
 41
observe any elimination product.  The reaction of diacetoxy sulfone 118 with β-keto esters 
provides a useful synthetic method for the preparation of complex bicyclic systems.   
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Scheme 43 
 
The reactions are operationally convenient and amenable to scale up to produce gram 
quantities of bicyclic compounds. With protocols in hand for the construction of the bicyclic 
unit, our attention was then directed at retooling the route toward bicyclic β-bromenone 140, 
which could be a key precursor to complete papuaforin B (4) synthesis.  Retrosynthetic 
analysis to papuaforin B (4) using diacetoxy sulfone 118 was proposed in Figure 5. 
Coupling reaction of allylic enone 138 and diacetoxy sulfone 118 could provide the 
adduct 139.  Potassium hydride mediated cyclization, elimination of sulfone moiety, 
protection of terminal olefin, and finally bromination using NBS would give the key bicyclic 
β-bromoenone 140.   
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Figure 5. Retrosynthetic analysis of papuaforin B (4) 
 
Synthesis of β-keto ester 138 commenced with C-methylation of 5,5-
dimethylcyclohexane-1,3-dione using methyl iodide and 4N aqueous NaOH.  O-Methylation 
of β-diketone 142, and subsequent allylation of 143 gave enone 144 in good overall yield.  
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Reduction of 144 followed by rearrangement under acidic condition provided allylic 
enone 145 in a 98% yield, which was then converted into β-keto ester 138 by the treatment of 
the enolate and methyl cyanoformate.  β-Keto ester 138 was treated with vinylic sulfone 118 
in the presence of NaH.  Contrary to our expectation, the desired Michael addition adduct 
139 was not obtained.  Unreacted 138 was recovered even under conditions utilizing different 
bases, such as LDA and KH.   
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Kende and co-workers discovered a Pd(II)-mediated intramolecular cycloalkenylation 
of silyl enol ether 146 (Scheme 46).37  We performed a model study to test its applicability to 
our system. 
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The synthesis of the model system commenced with allylation of 2,6-dimethyl-
cyclohexanone using KH and allyl bromide (Scheme 47).  Due to steric hindrance in ketone 
150, an elevated reaction temperature was necessary to prepare enol silyl ether 151.  The 
attempted intramolecular cycloalkenylation of 151 using Pd(OAc)2 following Kende’s 
protocol furnished the desired bicyclo[3.3.1]nonene ring system 152 in a 60% yield. 
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This successful result encouraged us to apply this method to our real system.  Firstly, 
enone 138 was allylated using NaH and allyl bromide in boiling THF.  The allylic enone 153 
was then reduced by L-selectride to give ketone 154 as a 3:1 mixture of diastereomers in a 
83% yield.  The silylation of 154, followed by the Pd(II)-mediated cycloalkenylation, 
afforded 156 in a 50% yield.   
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The terminal olefin in 156 was selectivly oxidized to the corresponding diol, which 
was then protected as a carbonate group with triphosgene in the presence of pyridine at low 
temperature to yield 157.  At this point, the equatorial stereochemistry of the carbonate side 
chain of 157 was confirmed by x-ray crystallography as shown in Scheme 49.  The fully 
elaborated bicyclo[3.3.1]nonane skeleton of 157 is stereochemically well matched with 
papuaforin B (4). 
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Unfortunately, bromination of 157 failed to give β-bromoenone 159. Enone 158 was 
achieved as the sole product (Scheme 50).  The steric hindrance between bromine at C4 and 
the bridgehead methyl group at C5 of 157a seemed to prevent a further bromination leading 
to tribromide 157b (Scheme 51). 
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The rapid hydrolysis of 157a gave enone 158.  In a recent report from Corey’s group, 
an interesting transformation to obtain a β-diketone from a silyl enol ether was described.38  
The Pd(OH)2-catalyzed oxidation of silyl enol ether 160 by t-BuOOH produces either β-
silyloxy enone 161 or enone 162 depending on the base used (Scheme 52). 
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In order to test its applicability to our system, the previously synthesized ketone 40 
was first converted to the corresponding silyl enol ether 163 using triisopropylsilyl 
trifluoromethanesulfonate and triethylamine (Scheme 53).  Following Corey’s method, 
treating 163 with Pd(OH)2 and t-BuOOH in the presence of Cs2CO3, only generated enone 41.  
However, when 163 was exposed to the bromination conditions, the desired β-bromoenone 
164  was achieved in a 63% yield, presumably via dibromination at C2, followed by 
elimination. 
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Scheme 53 
 
Based on the result shown in Scheme 53, the synthesis of a fully substituted β-
bromoenone precursor was started from the Michael addition of 138 using methyl acrylate 
and t-BuOH.  With the adduct 165 in hand, we examined cyclization reactions with the idea 
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of employing the two sequential reactions (Scheme 54).  The selective reduction of α,β-
enone, followed by intramolecular cyclization, should furnish bicyclic ketone 167. 
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Our first attempt using L-selectride was unsuccessful.  It generated the 
spirocyclization product 168.  However, reduction of 165 using excess Na/NH3 produced 
bicyclic diol 169 in about 10% yield (Scheme 55).  After many attempts to optimize this step, 
the reaction yield was improved to 85%.   
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Scheme 55 
 
Although the mechanism for this step is still unclear, we postulated that the enone is 
initially reduced by two equivalents of sodium metal (Scheme 56).  The resulting enolate 
165b does not undergo cyclization until the less hindered ester group is reduced to a more 
reactive aldehyde group.  Indeed, the reaction using only two equivalents of sodium metal 
gave 165a without generating any cyclization product as shown in Scheme 55.  The 
intramolecular cyclization of 165c, followed by the third reduction of ketone function in 167, 
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gives diol 169.  The sterically congested ester group at the C1 position was not reduced under 
the conditions.  The reaction yields were significantly lower when more or less than six 
equivalents of sodium metal were used. 
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Scheme 56 
 
Bicyclic diol 169 was oxidized using pyridinium chlorochromate to give ketone 167 
in an 87% yield (Scheme 57).  In order to ensure selectivity during the bromination reaction, 
the allylic side chain at C7 was converted to a relatively stable carbonate function by 
dihydroxylation, followed by protection of the diol group.  Enol silyl ether formation leading 
to 171 occurred employing KH and TIPSOTf.  Bromoenone precursor 172, where the allyl 
group was not protected, was also prepared in the same manner to examine the 
regioselectivity of the bromination reaction. 
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Scheme 57 
 
We first examined the bromination reaction of 171 using two equivalents of NBS 
(Scheme 58).  Surprisingly, it generated α-bromoene 173, instead of the expected β-
bromoenone 174.  
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Bromination of 172 also furnished α-bromoenone 175 employing the same reaction 
conditions.  Interestingly, brominations only occurred on the enol silyl ether moiety without 
affecting the allyl group, and the reaction yield as improved to 75% by boiling (Scheme 59).   
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Scheme 59 
 
We confirmed the structure of 175 based on 1H NMR and NOESY spectra (Scheme 
60).  In the 1H NMR spectrum, the proton signal at C3 of 164, obtained either from 176 or 
163, is 7.02 ppm, whereas that of 175 is shifted downfield (7.64 ppm).  Furthermore, a 
notable interaction between the methyl group at C8 and the proton at C2 of 175 was observed 
in the NOESY experiment, which strongly supports the structure of 175.  The possible 
mechanism for formation of 175 is shown in Scheme 60.  The first bromination may occur at 
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C3, which leads to intermediate 172b.  The second bromination either at C2 or C3 followed 
by dehydrobromination forms α-bromoenone 175. 
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Scheme 60 
 
The bromide 175 was coupled with the TBS-protected acetylene 176 under 
Hagihara’s conditions39 to give 177 in a 70% yield (Scheme 61).  
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The selective reduction of the acetylene moiety of 178 to a cis-alkene using Lindlar’s 
catalyst, followed by in situ Michael addition, would generate 179 (Scheme 62).  Upon 
oxidation of 179, the synthesis of the fully substituted tricyclic core of papuaforin B (4) 
would be realized. 
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In conclusion, a concise and efficient synthetic route to the highly funtionalized 
tricyclic core skeleton of papuaforin B (4) was examined.  In the course of the synthesis, an 
efficient cyclization method using Na/NH3 was demonstrated.  We also developed a novel 
bromination method leading to an α-bromoenone that would serve as a handle for 
construction of the fused pyran ring.  Cross-metathesis of the terminal alkene to the prenyl 
group, and transformation of the ester to an isobutyryl unit at C1 would complete the 
synthesis of papuaforin B (4).  Further efforts along this line are in progress. 
 
Experimental 
Unless otherwise noted, materials were obtained from commercial suppliers and used 
without purification.  Tetrahydrofuran and diethyl ether were distilled from sodium and 
benzophenone.  Dichloromethane, benzene and diisopropyl amine were distilled over 
calcium hydride.  All experiments were performed under an argon atmosphere unless 
otherwise noted.  Organic extracts were dried over anhydrous magnesium sulfate. Infrared 
spectra were obtained on a Perkin-Elmer model 1320 spectrophotometer.  Nuclear magnetic 
resonance experiments were performed with either a Varian 300 MHz or Bruker 400 MHz 
instrument.  All chemical shifts are reported relative to CDCl3 (7.27 ppm for 1H and 77.23 
ppm for 13C), unless otherwise noted.  Coupling constants (J) are reported in Hz with 
abbreviations: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet.  High resolution 
mass spectra were recorded on a Kratos model MS-50 spectrometer.  Standard grade silica 
gel (60 Å, 32-63 μm) was used for flash column chromatography. 
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5-Benzoyl-4-bromobicyclo[3.3.1]non-3-ene-2,9-dione (64) 
To a solution of 5-benzoylbicyclo[3.3.1]non-2-en-9-one in dry CCl4 was added dry 
NBS (3.5 equiv.) and AIBN (0.1 equiv.). The flask was fitted with a reflux condenser and 
irradiated with a sun lamp. After 1.5 h (monitored by TLC), the mixture was allowed to cool 
to rt and filtered. The crude material was purified by column chromatography to yield the 
bromo enone 1 in a 73% yield: 1H NMR (300 MHz, CDCl3) δ 7.77 (d, J = 8.1 Hz, 2H), 7.55 
(t, J = 7.8 Hz, 1H), 7.41 (t, J = 7.8 Hz, 2H), 7.13 (s, 1H), 3.54 (t, J = 3.9 Hz, 1H), 2.44-1.72 
(m, 6H); 13C NMR (75 MHz, CDCl3) δ 204.84, 193.70, 192.94, 148.49, 136.07, 135.22, 
133.68, 128.86, 128.81, 63.05, 34.60. 33.82, 25.31, 17.54. 
 
O O
Ph
O OH
 
3-Allyl-5-benzoyl-4-hydroxybicyclo[3.3.1]non-3-ene-2,9-dione (68) 
To a solution of allyl alcohol (20 equiv.) at 0 oC was added freshly cut sodium metal 
(1.1 equiv.), bromoenone 64 (1 equiv.) in allyl alcohol was added and the mixture was 
allowed to stir for 1 h. After aqueous work-up, the crude material was purified by column 
chromatography. The allyl enol ether was then dissolved in dry toluene and placed in a sealed 
tube, where it was heated at 170 oC for 7 h. Compound was purified by column 
chromatography: FTIR (thin film) 1682, 1635, 1596, 1569 cm−1; 1H NMR (300 MHz, 
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CDCl3) δ 7.98 (d, J = 8 Hz, 2H), 7.61 (t, J = 7.5, 1H), 7.50 (t, J = 7.8, 2H), 6.02–5.89 (m, 
1H), 5.36–5.20 (m, 2H), 4.57 (t, J = 5.4, 1H), 3.32 (d, J = 6.3, 2H), 2.59–2.50 (m, 1H), 2.40–
2.30 (m, 1H), 2.13–2.03 (m, 2H), 1.79–1.67 (m, 2H); 13C NMR (75 MHz, CDCl3) δ 198.27, 
164.95, 164.74, 155.23, 135.51, 135.39, 133.87, 129.06, 128.89, 117.84, 111.88, 100.86, 
45.24, 28.46, 26.70, 20.51, 18.57; HRMS (EI) m/z calcd for 310.12051, found 310.12098. 
 
O
O
 
9-Allyl-10,10-dimethyltricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-8,13-dione (75) 
To a stirred solution of Mn(OAc)3 dihydrate (2 equiv.) and Cu(OAc)2 monohydrate (1 
equiv.) in degassed glacial acetic acid at rt was added a solution of 2-allyl-2-benzoyl-3,3-
dimethylcyclohexanone (1 equiv.) in glacial acetic acid. The mixture was stirred at 90 oC for 
16 h. After normal aqueous work-up, the crude material was purified by column 
chromatography to yield the compound 3 in 76% yield: 1H NMR (300 MHz, CDCl3) δ 8.08 
(d, J = 7.8 Hz, 1H), 7.58 (t, J = 7.2 Hz, 1H), 7.40 (t, J = 7.2 Hz, 1H), 7.25 (d, J = 7.5 Hz, 1H), 
5.57-5.43 (m, 1H), 5.10-4.88 (m, 2H), 3.82 (t, J = 3.3 Hz, 1H), 2.75-2.58 (m, 2H), 2.45-2.33 
(m, 1H), 1.85-1.77 (m, 1H), 1.55-1.44 (m, 1H), 1.29-1.17 (m, 1H), 1.07 (s, 3H), 0.99 (s, 3H); 
13C NMR (75 MHz, CDCl3) δ 209.28, 197.50, 141.22, 135.29, 134.92, 134.25, 128.09, 
127.78, 126.80, 118.21, 72.89, 53.42, 45.52, 33.54, 31.45, 29.76, 25.60, 22.52. 
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3,3-Diacetoxy-2-(phenylsulfonyl)propene (118) 
To a mechanically stirred suspension of 6.8 g (0.05 mol) of N-chlorosuccinimide in 
60 mL of dry methylene chloride at room temperature in a 250 mL flask equipped with a 
pressure-equalizing dropping funnel and an efficient condenser was added about 0.5 g of a 
total of 5.5 g (0.05 mol) of thiophenol. The mixture was then gently heated on a steam bath 
for 1 to 2 min until sulfenyl chloride formation commenced as evidenced by the intense 
orange coloration of the suspension. Once initiated, the remaining thiophenol was added 
dropwise at a rate sufficient to maintain the solvent at reflux. When the addition was 
complete (usually about 30 min were required), the homogeneous orange solution was stirred 
at room temperature for an additional 30 min. The suspension was then cooled to 0 °C and 
8.7 g (0.055 mol) of 1,1-diacetoxy-2-propene was added in one portion. The mixture was 
then maintained at 0 °C until complete decoloration of the sulfenyl chloride suspension was 
observed (2 h). After warming to room temperature, the colorless suspension was filtered to 
remove the majority of the succinimide. Concentration of the combined filtrate and wash left 
a pale yellow oil, which was diluted with 30 mL of hexane to precipitate the remainder of the 
succinimide. This suspension was let stand 1 h and then filtered, and the filtrate was 
evaporated to dryness, which was pure enough to be used without further purification: 1H 
NMR (300 MHz, CDCl3) δ 7.53–7.49 (m, 2H), 7.38–7.31 (m, 3H), 7.14 (d, J = 3.6 Hz, 1H), 
3.84-3.68 (m, 2H), 3.63-3.58 (m, 1H), 2.09 (s, 3H), 2.08 (s, 3H). 
To a stirred solution of 4.4 g (0.02 mol) of chloro sulfide prepared above in 25 mL of 
dry methylene chloride, cooled to 0 °C under nitrogen, a solution of 2.2 equiv of m-
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chloroperbenzoic acid in 50 mL of methylene chloride was added dropwise. When the 
addition was complete, the mixture was stirred an additional 20 min and then filtered to 
remove the majority of the chlorobenzoic acid, which was washed with 30 mL of methylene 
chloride. The combined filtrate and wash was diluted with 50 mL of methylene chloride and 
then washed successively with 10% NaHCO3 (50 mL), 10% NaHSO3 (50 mL), 10% NaHCO3 
again (50 mL ), and saturated brine and finally dried (MgSO4), which was pure enough to be 
used without further purification: 1H NMR (300 MHz, CDCl3) δ 7.98–7.94 (m, 2H), 7.76–
7.60 (m, 3H), 7.23 (d, J = 3.0 Hz, 1H), 4.17-3.94 (m, 2H), 3.88-3.83 (m, 1H), 2.07 (s, 3H), 
2.02 (s, 3H) 
A solution of 1.3 mL (7.5 mmol) of diisopropylethylamine in 50 mL of dry methylene 
chloride was added dropwise, under a nitrogen atmosphere, to a stirred solution of 2.3 g (6.9 
mmol) of chlorosulfone at -10 °C. The reaction temperature was maintained at 0 °C for 2 h, 
then diluted with 40 mL of methylene chloride, washed with 25 mL each of chilled 1 N HCI, 
water, and brine, and finally dried over anhydrous magnesium sulfate. Recrystallization with 
diethylether/hexane gave compound 118 as a white solid: mp 64–67 oC; 1H NMR (300 MHz, 
CDCl3) δ 7.92–7.89 (m, 2H), 7.69–7.54 (m, 3H), 7.39 (s, 1H), 6.75 (s, 1H), 6.36 (s, 1H), 1.96 
(s, 6H); 13C NMR (75 MHz, CDCl3) δ 167.95, 145.84, 139.68, 134.05, 129.53, 129.43, 
128.55, 84.90, 20.61; HRMS (EI) m/z (M+ - CH3CO2) calcd for 239.03781, found 239.03830.   
 
General procedure for Michael addition to 118 
The keto ester (1 mmol) was added dropwise to the solution of sodium hydride (1 
mmol) in THF (10 mL). After 20 min, sulfone 7 (1 mmol) was added in one portion and 
stirred for another 1 h. The resulting mixture was neutralized with AcOH, which was 
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dissolved in 20 ml of ether. The ether layer was washed with brine and dried over anhydrous 
MgSO4. The crude material was purified by column chromatography. 
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(2E)-1-[3-Acetoxy-2-(benzenesulfonyl)allyl]-2,2,5-trimethyl-6-oxocyclohexanecarboxylic 
acid methyl ester (121): 1H NMR (300 MHz, CDCl3) δ 8.29 (d, J = 3.3 Hz, 1H), 7.88 (d, J = 
7.8 Hz, 2H), 7.67–7.52 (m, 3H), 3.67 (s, 3H), 3.31 (d, J = 16.8 Hz, 1H), 2.90 (d, J = 16.8 Hz, 
1H), 2.23 (s, 3H), 1.87–1.34 (m, 4H), 0.92 (s, 6H), 0.74 (d, J = 6.3 Hz, 3H); 13C NMR (75 
MHz, CDCl3) δ 206.44, 169.59, 166.20, 145.45, 139.58, 133.78, 129.58, 128.27, 123.20, 
65.43, 51.43, 42.46, 40.53, 36.20, 30.56, 28.73, 26.28, 25.55, 20.75, 15.27; HRMS (EI) m/z 
calcd for 436.15558, found 436.15630. 
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O
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(2E)-1-[3-Acetoxy-2-(benzenesulfonyl)allyl]-2,2-dimethyl-6-oxocyclohexanecarboxylic 
acid methyl ester (127): 1H NMR (300 MHz, CDCl3) δ 8.14 (s, 1H), 7.91 (d J = 7.5 Hz, 2H), 
7.64–7.51 (m, 3H), 3.46 (s, 3H), 2.65-2.50 (m, 2H), 2.33-1.21 (m, 6H), 2.02 (s, 3H), 0.91 (s, 
3H), 0.72 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 207.50, 170.76, 165.72, 142.24, 139.73, 
133.47, 129.16, 128.04, 125.55, 66.73, 51.65, 44.17, 39.17, 36.25, 26.72, 26.62, 22.75, 22.53, 
20.37; HRMS (EI) m/z calcd for 422.13993, found 422.14080. 
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(2E)-1-[3-Acetoxy-2-(benzenesulfonyl)allyl]-2-oxocyclohexanecarboxylic acid methyl 
ester (132); 1H NMR (300 MHz, CDCl3) δ 8.47 (s, 1H), 7.87-7.83 (m, 2H), 7.63–7.50 (m, 
3H), 4.26-4.17 (m, 2H), 2.90-2.76 (m, 2H), 2.52-1.56 (m, 8H), 2.20 (s, 3H), 1.32-1.24 (m, 
3H); 13C NMR (75 MHz, CDCl3) δ 206.27, 170.67, 165.89, 146.91, 139.82, 133.49, 129.30, 
128.07, 124.08, 61.69, 59.98, 40.62, 35.11, 28.89, 27.07, 22.39, 20.59, 13.98; HRMS (EI) 
m/z calcd for 408.12428, found 408.12500. 
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(2E)-1-[3-Acetoxy-2-(benzenesulfonyl)allyl]-3-methyl-2-oxocyclohex-3-enecarboxylic 
acid methyl ester (134): 1H NMR (300 MHz, CDCl3) δ 8.40 (s, 1H), 7.81-7.76 (m, 2H), 
7.58–7.43 (m, 3H), 6.57 (br s, 1H), 3.62 (s, 3H), 3.99 (d, J = 15.6 Hz, 1H), 2.75 (d, J = 15.6 
Hz, 1H), 2.45-2.19 (m, 2H), 2.13 (s, 3H), 1.95-1.88 (m, 2H), 1.73 (s, 3H); 13C NMR (75 
MHz, CDCl3) δ 194.93, 171.22, 166.06, 146.92, 144.91, 139.65, 134.81, 133.71, 129.46, 
128.30, 124.10, 56.08, 52.81, 30.20, 28.93, 23.67, 20.69, 16.84, 14.34. 
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(2E)-1-[3-Acetoxy-2-(benzenesulfonyl)allyl]-2-oxocyclopentanecarboxylic acid ethyl 
ester: 1H NMR (300 MHz, CDCl3) δ 8.48 (s, 1H), 7.87-7.83 (m, 2H), 7.64–7.51 (m, 3H), 
4.19-4.08 (m, 2H), 3.09 (d, J = 15.6 Hz, 1H), 2.63 (d, J = 15.6 Hz, 1H), 2.39-2.30 (m, 2H), 
2.22 (s, 3H), 2.03-1.91 (m, 2H), 1.21 (t, J = 6.9 Hz 3H); 13C NMR (75 MHz, CDCl3) δ 
214.17, 171.14, 166.03, 146.31, 138.85, 133.79, 129.42, 128.49, 124.00, 62.00, 59.04, 37.53, 
31.92, 27.70, 20.65, 19.86, 14.11. 
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(4E)-5-Acetoxy-4-benzenesulfonyl-2-methyl-2-propionylpent-4-enoic acid ethyl ester: 1H 
NMR (300 MHz, CDCl3) δ 8.48 (s, 1H), 7.84-7.81 (m, 2H), 7.63–7.49 (m, 3H), 4.28-4.09 (m, 
2H), 3.05 (d, J = 15.6 Hz, 1H), 2.84 (d J = 15.6 Hz, 1H), 2.61-2.2.45 (m, 2H), 2.20 (s, 3H), 
1.33 (s, 3H), 1.27 (t, J = 7.2 Hz, 3H), 1.06 (t, J = 7.2 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 
207.45, 172.38, 166.02, 146.66, 139.27, 133.68, 129.38, 128.37, 124.22, 61.95, 58.62, 31.64, 
28.75, 20.69, 18.64, 14.08, 8.365. 
 
Procedure for cyclizations using t-BuOK 
To a stirred solution of diketone (1 mmol) in THF (10 mL) was added t-BuOK (1 
mmol) in one portion at 0 oC. The mixture was stirred overnight at rt and dissolved in 20 ml 
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of ether. The ether layer was washed with 10 % aq. HCl, brine and dried over anhydrous 
MgSO4. The crude material was purified by column choromatography. 
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7-Benzenesulfonyl-6-hydroxy-2,2,5-trimethyl-9-oxobicyclo[3.3.1]nonane-1-carboxylic 
acid methyl ester (122): 1H NMR (300 MHz, CDCl3) δ 7.95-7.89 (m, 2H), 7.76–7.54 (m, 
3H), 4.52 (d, J = 10.5 Hz, 1H), 3.85 (s, 1H), 3.48 (s, 3H), 3.13-3.03 (m, 1H), 2.05-1.25 (m, 
6H), 1.12 (s, 6H), 1.04 (s, 3H), 0.93(s, 3H); 13C NMR (75 MHz, CDCl3) δ 208.94, 170.13, 
136.07, 134.92, 129.81, 129.35, 74.31, 66.17, 64.63, 52.29, 51.27, 42.93, 37.81, 29.30, 28.41, 
26.48, 25.54, 20.90; HRMS (EI) m/z calcd for 394.14501, found 394.14570. 
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6-Acetoxy-7-benzenesulfonyl-2,2,5-trimethyl-9-oxobicyclo[3.3.1]nonane-1-carboxylic 
acid methyl ester (123): 1H NMR (300 MHz, CDCl3) δ 7.88-7.83 (m, 2H), 7.71–7.56 (m, 
3H), 5.62 (d, J = 11.4 Hz, 1H), 3.68 (s, 3H), 3.45-3.33 (m, 1H), ), 2.76 (dd, J = 14.7, 4.8 Hz, 
1H), 2.47 (d, J = 14.4 Hz, 1H), 2.17-1.96 (m, 2H), 1.77-1.71 (m, 1H), 1.64 (s, 3H), 1.31-1.26 
(m, 1H), 1.13 (s, 3H), 1.11 (s, 3H), 0.86 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 209.80, 
170.86, 169.78, 139.47, 134.07, 129.50, 128.33, 74.83, 62.99, 61.07, 52.31, 49.84, 43.76, 
38.08, 33.74, 26.59, 24.58, 22.87, 20.30, 17.63. 
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3-Benzenesulfonyl-8a-hydroxy-5,5,8-trimethyl-6,7,8,8a-tetrahydro-4H,5H-chromene-
4a-carboxylic acid methyl ester (124): 1H NMR (300 MHz, CDCl3) δ 7.88 (m, 2H), 7.62–
7.49 (m, 3H), 7.49 (d, J = 1.8 Hz, 1H), 6.88 (d, J = 2.1 Hz, 1H), 3.19 (s, 3H), 2.82-2.61 (m, 
2H), 1.82-1.23 (m, 5H), 1.11-0.89 (m, 9H); 13C NMR (75 MHz, CDCl3) δ 174.63, 152.20, 
140.44, 132.87, 129.11, 127.55, 112.56, 105.36, 52.65, 52.22, 38.37, 36.04, 34.54, 27.70, 
27.46, 25.60, 24.99, 13.39; HRMS (EI) m/z calcd for 394.14501, found 380.97603. 
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3-Benzenesulfonyl-5,5-dimethyl-6,7-dihydro-4H,5H-chromene-4a-carboxylic acid 
methyl ester (131): 1H NMR (300 MHz, CDCl3) δ 7.88-7.84 (m, 2H), 7.65–7.52 (m, 3H), 
7.46 (d, J = 2.4 Hz, 1H), 5.59 (t, J = 4.2 Hz, 1H), 3.28 (s, 3H), 2.82 (d, J = 15.6 Hz, 1H), 2.33 
(dd, J = 15.6, 2.4 Hz, 1H), 2.17-2.09 (m, 2H), 1.63-1.55 (m, 1H), 1.33-1.28 (m, 1H), 0.98 (s, 
3H), 0.85 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 171.44, 150.63, 147.13, 140.34, 133.15, 
129.22, 127.92, 115.84, 109.73, 52.19, 51.04, 35.47, 33.90, 25.63, 24.23, 20.29; HRMS (EI) 
m/z calcd for 362.11880, found 362.11940. 
 
Procedure for cyclizations using KH 
To a stirred solution of potassium hydride (1 mmol) in THF (10 mL) was added the 
diketone (1 mmol). The mixture was stirred overnight at rt and dissolved in 20 ml of ether. 
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The ether layer was washed with 10 % aq. HCl, brine and dried over anhydrous MgSO4. The 
crude material was purified by column choromatography. 
 
O
O
O
SO2Ph
PivO
 
7-Benzenesulfonyl-6-(2,2-dimethylpropionyloxy)-2,2-dimethyl-9-
oxobicyclo[3.3.1]nonane-1-carboxylic acid methyl ester (130): 1H NMR (300 MHz, 
CDCl3) δ 7.89-7.86 (m, 2H), 7.72–7.56 (m, 3H), 5.40 (d, J = 10.8 Hz, 1H), 4.12-4.00 (m, 2H), 
3.49-3.39 (m, 1H), ), 2.48-1.80 (m, 6H), 1.27-1.21 (m, 1H), 1.15-1.06 (m, 18H); 13C NMR 
(75 MHz, CDCl3) δ 209.06, 177.39, 170.00, 138.41, 134.41, 129.68, 128.70, 73.82, 62.92, 
61.18, 60.78, 54.22, 44.08, 38.71, 33.95, 28.62, 28.44, 27.00, 24.71, 22.73, 14.14; HRMS 
(EI) m/z calcd for 478.20253, found 478.20310. 
 
O
SO2Ph
PivO
CO2Et
 
3-Benzenesulfonyl-4-(2,2-dimethylpropionyloxy)-9-oxobicyclo[3.3.1]nonane-1-
carboxylic acid ethyl ester (133): 1H NMR (300 MHz, CDCl3) δ 7.94-7.89 (m, 2H), 7.73–
7.57 (m, 3H), 5.54 (dd, J = 10.5 Hz, 0.9 Hz, 1H), 4.27-4.11 (m, 3H), 3.46-3.36 (m, 1H), 3.01-
2.75 (m, 2H), 2.32 (br s, 1H), 2.28-1.51 (m, 6H), 1.18 (t, J = 10.2 Hz 3H), 1.12 (s, 9H); 13C 
NMR (75 MHz, CDCl3) δ 209.27, 177.41, 171.28, 138.23, 134.44, 129.69, 128.82, 73.26, 
61.97, 60.19, 56.39, 55.01, 38.73, 38.06, 34.17, 29.03, 26.99, 17.70, 14.23; HRMS (EI) m/z 
calcd for 450.17123, found 450.17200. 
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3-Benzenesulfonyl-4-(2,2-dimethylpropionyloxy)-5-methyl-9-oxobicyclo[3.3.1]nonane-1-
carboxylic acid methyl ester (135): 1H NMR (300 MHz, CDCl3) δ 7.83 (d, J = 8.4 Hz, 2H), 
7.71–7.54 (m, 3H), 5.51 (d, J = 1.5 Hz, 1H), 3.73 (s, 3H), 2.88 (br s, 1H), 2.67 (d, J = 12.3 
Hz, 1H), 2.49 (dd, J = 12.3, 1.8 Hz, 1H), 2.31-1.81 (m, 6H), 1.27 (s, 3H), 0.90 (s, 9H); 13C 
NMR (75 MHz, CDCl3) δ 207.59, 176.57, 170.40, 136.35, 134.57, 129.64, 129.48, 72.68, 
65.73, 58.61, 55.46, 52.67, 39.45, 38.79, 31.21, 28.86, 26.81, 16.53, 15.14; HRMS (EI) m/z 
calcd for 450.17123, found 450.17190. 
 
General procedure for pivaloyl group substitution 
To a stirred solution of diketone (1 mmol) in THF (10 mL) was added t-BuOK (2 
mmol) in one portion at 0oC. The reaction temperature was maintained at 0°C for 1 h, then 
trimethylacetyl chloride (2 mmol) was added. The resulting mixture was neutralized with 
AcOH, which was dissolved in 20 mL of ether. The ether layer was washed with brine and 
dried over anhydrous MgSO4. The crude material was purified by column choromatography. 
 
O
O
O
SO2Ph
PivO
 
(2E)-1-[2-Benzenesulfonyl-3-(2,2-dimethylpropionyloxy)allyl]-2,2,5-trimethyl-6-
oxocyclohexanecarboxylic acid methyl ester (125): 1H NMR (300 MHz, CDCl3) δ 8.32 (d, 
J = 0.9 Hz, 1H), 7.84 (d, J = 8.7 Hz, 2H), 7.62–7.49 (m, 3H), 3.65 (s, 3H), 3.21 (dd, J = 15.6, 
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0.9 Hz, 1H), 2.99 (d, J = 15.6 Hz, 1H), 2.04-1.38 (m, 4H), 1.25 (s, 9H), 1.00-0.95 (m, 9H); 
13C NMR (75 MHz, CDCl3) δ 207.02, 173.77, 170.68, 147.20, 140.17133.47, 129.30, 128.09, 
124.61, 66.63, 51.52, 41.98, 41.23, 39.11, 36.17, 29.92, 27.53, 26.69, 26.26, 25.45, 15.41; 
HRMS (EI) m/z calcd for 478.20253, found 478.20320. 
 
O
O
O
SO2Ph
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(2E)-1-[2-Benzenesulfonyl-3-(2,2-dimethylpropionyloxy)allyl]-2,2-dimethyl-6-oxo-
cyclohexanecarboxylic acid methyl ester (129): 1H NMR (300 MHz, CDCl3) δ 8.36 (s, 1H), 
7.91 (d, J = 7.8 Hz, 2H), 7.64–7.51 (m, 3H), 3.51 (s, 3H), 3.21-3.10 (m, 1H), 2.88 (dd, J = 
15.9, 1.2 Hz, 1H), 2.57 (d, J = 15.9 Hz, 1H), 2.38-2.32 (m, 1H), 2.11-2.00 (m, 1H), 1.90-1.67 
(m, 2H), 1.34-1.28 (m, 1H), 1.21 (s, 9H), 1.10 (s, 3H), 0.74 (s, 3H); 13C NMR (75 MHz, 
CDCl3) δ 206.40, 174.50, 170.19, 145.62, 140.27, 133.29, 129.10, 128.18, 125.34, 67.25, 
51.65, 43.79, 40.02, 39.13, 36.56, 26.74, 24.93, 22.86, 22.49; HRMS (EI) m/z calcd for 
464.18688, found 464.18760. 
 
2.6. Procedure for tosyl group substitution 
To a stirred solution of 127 (422 mg, 1 mmol) in THF (10 mL) was added t-BuOK 
(224 mg, 2 mmol) in one portion at 0 oC. The reaction temperature was maintained at 0 oC 
for 1 h, then p-toluenesulfonyl chloride (381 mg, 2 mmol) was added. The resulting mixture 
was neutralized with AcOH, which was dissolved in 20 mL of ether. The ether layer was 
washed with brine and dried over anhydrous MgSO4. The crude material was purified by 
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column chromatography. 
 
O
O
O
SO2Ph
TsO
 
(2E)-1-[2-Benzenesulfonyl-3-(p-toluenesulfonyloxy)allyl]-2,2-dimethyl-6-oxo-
cyclohexanecarboxylic acid methyl ester (128): 1H NMR (300 MHz, CDCl3) δ 7.92-7.39 
(m, 10H), 3.49 (s, 3H), 2.49 (s, 3H), 2.09-1.53 (m, 6H), 1.26-1.11 (m, 2H), 0.86 (s, 3H), 0.67 
(s, 3H); 13C NMR (75 MHz, CDCl3) δ 207.06, 169.82, 146.56, 143.13, 139.22, 133.60, 
131.51, 130.15, 129.14, 128.51, 127.98, 126.70, 66.52, 51.78, 43.93, 38.85, 36.05, 26.50, 
26.48, 22.49, 22.42, 21.90; HRMS (EI) m/z calcd for 534.13821, found 534.13900. 
 
2.7. Procedure for acetoxysulfone elimination 
The sulfone 136 (43.6 mg, 0.1 mmol) in methanol (1 mL) and ethyl acetate (0.5 mL) 
was stirred at 0 oC with 5% sodium amalgam. After 3 h, the mixture was poured into water (5 
mL) and extracted with ether three times. The combined organic layer washed with brine and 
dried over anhydrous MgSO4. The crude material was purified by column chromatography. 
 
O
CO2Me
 
5,8,8-Trimethyl-9-oxobicyclo[3.3.1]non-3-ene-1-carboxylic acid methyl ester (112): 1H 
NMR (300 MHz, CDCl3) δ 5.81 (dt, J = 9.3, 3.6 Hz, 1H), 5.29 (d, J = 9.3, 1H), 3.71 (s, 3H), 
3.13–2.83 (m, 2H), 2.06–1.52 (m, 3H), 1.24–1.167 (m, 1H), 1.11 (s, 3H), 1.09 (s, 6H); 13C 
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NMR (75 MHz, CDCl3) δ 210.70, 171.64, 132.74, 127.86, 64.83, 51.86, 46.23, 42.73, 36.89, 
36.20, 35.02, 25.46, 25.06, 21.85; HRMS (EI) m/z calcd for 236.14124, found 236.14170. 
 
O O
 
3-Methoxy-2,5,5-trimethylcyclohex-2-enone (143) 
5,5-Dimethyl-l,3-cyclohexanedione (28 g, 200 mmol) was added to an aqueous 
NaOH solution (60 mL, 4 M). The solution was placed in an ice bath, followed by addition of 
iodomethane (25 mL, 400 mmol) via syringe. The ice bath was removed, and the solution 
was allowed to reflux for 24 h and cooled to room temperature. Excess iodomethane was 
evaporated, and then 60 mL of 4 M aqueous NaOH was added and extracted with ethyl 
acetate (2 x 100 mL) to eliminate dimethylated by-product. After the aqueous layer was 
acidified with 10% HCl, the crystals of 142 were collected. Upon filtration and air-dry, 142 
was obtained in 90% purity, which was used for the next step without further purification. 
The methylated diketone 142 (12.5 g, 81 mmol) was dissolved in acetone (200 mL), and then 
dimethyl sulfate (6.9 mL, 73 mmol) and potassium carbonate (13.4 g, 97 mmol) was added. 
The resulting mixture was stirred overnight, and filtered and the solvent was removed under 
reduced pressure. The residue was purified by column chromatography on silica gel 
(EtOAc/hexane, 1:2) to provide 143 as a white crystal (11.2 g, 91%): mp 55–57 oC; 1H NMR 
(300 MHz, CDCl3) δ 3.80 (s, 3H), 2.41 (d, J = 1.5 Hz, 2H), 2.24 (s, 2H), 1.70 (t, J = 1.5 Hz, 
3H), 1.09 (s, 6H); 13C NMR (75 MHz, CDCl3) δ 198.70, 169.97, 113.73, 55.27, 50.27, 38.91, 
32.08, 28.73, 7.24. 
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6-Allyl-3-methoxy-2,5,5-trimethylcyclohex-2-enone (144) 
To a cooled (-78 oC), stirred solution of 2,2,6,6-tetramethylpiperidine (9.85 mL, 58 
mmol) in THF (100 ml) was added n-BuLi (23.2 mL of 2.5 M solution in hexane, 58 mmol). 
The mixture was stirred for 10 min at 0 oC and then cooled to -78 oC followed by the addition 
of 3-methoxy-2,5,5-trimethylcyclohex-2-enone (8.82 g, 53 mmol) in THF (20 mL). The 
resulting mixture was stirred for 2 h at -78 oC. After which, allyl bromide (5.02 mL, 58 
mmol) in THF (20 mL) was added. The temperature was raised to -15 oC (dry ice, acetone 
and water) and stirred overnight, at which time the reaction temperature was slowly warmed 
to room temperature. The solution was diluted with water and extracted with ether. The 
combined organic layers were washed with water and brine, which was dried over MgSO4 
and the solvent was removed under reduced pressure. The residue was purified by column 
chromatography on silica gel (EtOAc/hexane, 1:7) to provide 144 (8.82 g, 80%): 1H NMR 
(300 MHz, CDCl3) δ 5.94-5.80 (m, 1H), 5.03-4.92 (m, 2H), 3.79 (s, 3H), 2.49-2.27 (m, 4H), 
2.11 (dd, J = 8.4, 5.1 Hz, 1H), 1.69 (s, 3H), 1.10 (s, 3H), 1.02 (s, 3H); 13C NMR (75 MHz, 
CDCl3) δ 200.78, 168.00, 137.97, 115.31, 56.47, 55.07, 38.12, 34.83, 31.35, 29.21, 24.82, 
7.49; HRMS (EI) m/z calcd for 208.14623, found 208.14653. 
 
O
 
4-Allyl-2,5,5-trimethylcyclohex-2-enone (145) 
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To a cooled (0 oC), stirred solution of lithium aluminum hydride (1.52 g, 40 mmol) in 
100 mL of dry ether was slowly added 144 (8.32 g, 40 mmol). The reaction mixture was 
stirred for 3 h, followed by the addition of a minimum amount of water, and then filtered.  
After the solvent was evaporated, the alcohol was dissolved in THF (100 mL), and then 10% 
aqueous HCl (10 mL) was added. The resulting mixture was stirred for 0.5 h, and then 
diluted with ether (50 mL). The organic phase was separated from the aqueous phase and the 
aqueous phase was washed three times with 20 mL of ether. The combined organic phase 
was successively washed with water and brine, which was then dried over MgSO4 and the 
solvent was removed under reduced pressure. The crude product was purified by column 
chromatography (EtOAc/hexane, 1:20) to give 145 (6.99 g, 98%): 1H NMR (300 MHz, 
CDCl3) δ 6.51-6.50 (m, 1H), 5.90-5.77 (m, 1H), 5.17-5.11 (m, 2H), 2.48-2.24 (m, 4H), 1.95-
1.75 (m, 4H), 1.09 (s, 3H), 0.88 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 200.06, 146.54, 
136.84, 134.47, 117.31, 52.83, 46.30, 37.60, 33.69, 28.93, 21.42, 15.57; HRMS (EI) m/z 
calcd for 178.13577, found 178.13601. 
 
O O
O
 
5-Allyl-3,6,6-trimethyl-2-oxocyclohex-3-enecarboxylic acid methyl ester (138) 
To a cooled (-78 oC), stirred solution of 2,2,6,6-tetramethylpiperidine (5.6 mL, 33 
mmol) in THF (100 ml) was added n-BuLi (13.2 mL of 2.5 M solution in hexane, 33 mmol). 
The mixture was stirred for 10 min at 0 oC and then cooled to -78 oC, followed by the 
addition of 145 (5.34 g, 30 mmol) in THF (20 mL). The resulting mixture was stirred for 2 h 
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at -78 oC. After which, methyl cyanoformate (2.86 mL, 36 mmol) in THF (10 mL) was added 
and stirred for 3 h. It was poured into cold 10% aqueous HCl and extracted with ether. The 
combined organic layers were washed with brine and dried over MgSO4. After solvent was 
removed under reduced pressure, the residue was purified by column chromatography on 
silica gel (EtOAc/hexane, 1:20) to provide 138 as a mixture of diastereomers (6.38 g, 90%): 
1H NMR (300 MHz, CDCl3) δ 6.57 (s, 1H), 6.45 (s, 1H), 5.87-5.72 (m, 2H), 5.16-5.08 (m, 
4H), 3.73 (s, 3H), 3.66 (s, 3H), 3.36 (s, 1H), 3.17 (s, 1H), 2.69-2.65 (m, 1H), 2.43-2.26 (m, 
3H), 1.94-1.83 (m, 2H), 1.78-1.77 (m, 6H), 1.13 (s, 3H), 1.11 (s, 3H), 1.03 (s, 3H), 0.93 (s, 
3H); 13C NMR (75 MHz, CDCl3) δ 194.87, 169.91, 169.26, 147.68, 145.71, 136.54, 136.40, 
134.57, 133.16, 117.85, 117.61, 66.01, 64.85, 52.04, 51.75, 47.64, 43.14, 41.77, 39.50, 33.33, 
32.78, 26.34, 25.46, 23.20, 15.86, 15.54, 15.52; HRMS (EI) m/z calcd for 236.14124, found 
236.14153. 
O O
O
 
1,5-Diallyl-3,6,6-trimethyl-2-oxocyclohex-3-enecarboxylic acid methyl ester (153) 
To a stirred solution of NaH (1 g, 60% in mineral oil, 25 mmol) in THF (50 ml), 138 
(5.52 mL, 20 mmol) in THF (10 ml) was slowly added and stirred for 30 min, followed by 
the addition of allyl bromide (2.16 mL, 25 mmol) in THF (10 mL). The resulting mixture 
was refluxed overnight, and was cooled to room temperature. It was poured into sat. aqueous 
NH4Cl and extracted with ether. The combined organic layers were dried over MgSO4. After 
the solvent was removed under reduced pressure, the residue was purified by column 
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chromatography on silica gel (EtOAc/hexane, 1:20) to provide 153 (5.08 g, 92%): 1H NMR 
(300 MHz, CDCl3) δ 6.37 (s, 1H), 5.86-5.61 (m, 2H), 5.16-5.10 (m, 2H), 4.95-4.87 (m, 2H), 
3.72 (s, 3H), 2.92-2.85 (m, 1H), 2.46-2.35 (m, 3H), 1.93-1.81 (m, 1H), 1.77 (s, 3H), 1.05 (s, 
3H), 0.99 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 196.47, 171.26, 142.89, 136.72, 134.69, 
133.68, 117.80, 51.66, 42.25, 34.69, 33.71, 23.25, 20.27, 16.18. 
 
O O
O
 
1,3-Diallyl-2,2,5-trimethyl-6-oxo-cyclohexanecarboxylic acid methyl ester (154) 
To a cooled (-78 oC), stirred solution of 153 (4.14 g, 15 mmol) in THF (30 ml) was 
added L-selectride (16.5 mL of 1 M solution in THF, 16.5 mmol). The mixture was stirred 
for 40 min, and then warmed to room temperature. The resulting mixture was treated with 
10% NaOH/30% H2O2 (v/v = 25 mL/15 mL) stirred for 3 h. It was diluted with water and 
extracted with ethyl acetate. The combined organic layers were poured into cold 10% 
aqueous HCl and extracted with ether. The combined organic layers were washed with 10% 
aqueous sodium bisulfite and brine, and dried over MgSO4. After solvent evaporation, the 
residue was purified by column chromatography on silica gel (EtOAc/hexane, 1:20) to 
provide 154 as a 3:1 mixture of diastereomers (3.46 g, 83%).  
For the major diasteromeric compound (154a): 1H NMR (300 MHz, CDCl3) δ 5.84-
5.71 (m, 1H), 5.59-5.46 (m, 1H), 5.05-4.91 (m, 4H), 3.72 (s, 3H), 3.03-2.97 (m, 1H), 2.51 
(dd, J = 14.1, 9.3 Hz, 1H), 2.34-2.23 (m, 2H), 2.08-1.95 (m, 2H), 1.76-1.65 (m, 1H), 1.21-
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1.16 (m, 1H), 0.99-0.97 (m, 6H), 0.88 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 208.26, 170.88, 
137.66, 134.05, 117.55, 116.73, 70.13, 51.60, 42.75, 42.25, 41.32, 36.10, 35.36, 34.79, 23.50, 
20.46, 14.86. 
For the minor diasteromeric compound (154b): 1H NMR (300 MHz, CDCl3) δ 5.86-
5.61 (m, 2H), 5.03-4.91 (m, 4H), 3.59 (s, 3H), 3.13-3.04 (m, 1H), 2.68 (dd, J = 12.6, 4.8 Hz, 
1H), 2.50-2.44 (m, 1H), 2.18 (dd, J = 12.6, 9.6 Hz, 1H), 2.04-1.86 (m, 2H), 1.62-1.52 (m, 
1H), 1.43-1.39 (m, 1H), 1.36 (s, 3H), 1.02 (d, J=6.3 Hz, 3H), 0.86 (s, 3H); 13C NMR (75 
MHz, CDCl3) δ 210.28, 172.93, 138.37, 135.03, 117.73, 116.37, 66.29, 51.54, 46.51, 44.75, 
38.38, 35.29, 33.47, 33.04, 27.37, 23.81, 15.19. 
 
O
O
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7-Allyl-5,8,8-trimethyl-9-oxobicyclo[3.3.1]non-3-ene-1-carboxylic acid methyl ester 
(156) 
To a stirred solution of KH (1.48 g, 30% in mineral oil, 11.1 mmol) in THF (50 ml), 
154 (2.06 mL, 7.41 mmol) in THF (10 ml) was slowly added and refluxed for 1 h, after 
which, the reaction mixture was cooled to room temperature. Triethylamine (3.1 mL, 22.23 
mmol) and freshly distilled trimethylsilyl chloride (2.4 mL, 18.53 mmol) were then added, 
and the reaction was further stirred for 30 min. The resulting solution was diluted with 
hexane and filtered. After solvent was removed under reduced pressure, the silylated 
compound was dissolved in CH3CN (30 mL) followed by the addition of Pd(OAc)2 (1.66 g, 
7.41 mmol). It was stirred overnight, and the solvent was evaporated. The reaction solution 
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was filtered through a Celite pad, and the solid was washed repeatedly with pentane (100 
mL). The combined filtrates are concentrated under reduced pressure, and the residue was 
purified by column chromatography on silica gel (EtOAc/hexane, 1:10) to provide 156 (1.03 
g, 50%): 1H NMR (300 MHz, CDCl3) δ 5.83-5.60 (m, 2H), 5.33 (dt, J = 9.6, 1.8 Hz, 1H), 
5.04-4.95 (m, 2H), 3.73 (s, 3H), 3.18-2.83 (m, 2H), 2.35-2.28 (m, 1H), 2.05-1.96 (m, 1H), 
1.79-1.67 (m, 2H), 1.40-1.31 (m, 1H), 1.12 (s, 3H), 1.07 (s, 3H), 1.01 (s, 3H); 13C NMR (75 
MHz, CDCl3) δ 210.76, 171.79, 137.79, 133.62, 128.13, 116.39, 65.79, 51.94, 46.59, 45.38, 
43.18, 39.61, 36.28, 33.48, 23.30, 21.80, 18.36. 
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5-Allyl-1-(2-methoxycarbonylethyl)-3,6,6-trimethyl-2-oxo-cyclohex-3-enecarboxylic 
acid methyl ester (165)  
Keto ester 138 (2.7 g, 11.4 mmol), t-BuOK (256 mg, 2.28 mmol) and t-BuOH (1.1 
mL) in THF (23 mL) were stirred for 10 min, and then methyl acrylate (2.05 mL, 22.8 mmol) 
was added. The resulting mixture was stirred overnight, and then diluted with aq. NH4Cl and 
extracted with ether (30 mL x 2). The combined organic layers were dried over anhydrous 
MgSO4 and concentrated in vacuo. The residue was purified by column chromatography on 
silica gel (EtOAc/hexane, 1: 6) to furnish 165 (3.39 g, 91%): 1H NMR (300 MHz, CDCl3) δ 
6.39 (s, 1H), 5.84-5.70 (m, 1H), 5.14-5.08 (m, 2H), 3.71 (s, 3H), 3.59 (s, 3H), 2.54-2.28 (m, 
4H), 2.09-1.74 (m, 6H), 1.03 (s, 3H), 0.94 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 196.82, 
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173.97, 171.08, 143.89, 136.54, 133.18, 117.88, 51.73, 51.67, 42.49, 33.59, 30.05, 24.31, 
16.12; HRMS (EI) m/z calcd for 322.17802, found 322.17846. 
 
O
CO2Me
O
 
3-Allyl-2,2,5-trimethyl-6,9-dioxobicyclo[3.3.1]nonane-1-carboxylic acid methyl ester 
(167) 
In a 500 mL, 2-necked, round-bottomed flask fitted with a stirrer, and dry ice 
condenser were placed 165 (3.22 g, 10 mmol), t-BuOH (14.4 mL, 150 mmol), and dry THF 
(50 mL). To the cooled (-78 oC), stirred solution 150 mL of ammonia (NH3) was collected 
and then freshly cut sodium (1.38 g, 60 mmol) was portionwise added over 10 min. The 
resulting mixture was further stirred for 1 h until all the sodium was consumed, and NH4Cl 
powder (5 g) was added. The temperature of the bath was allowed to rise gradually to room 
temperature, and the reaction was stirred overnight to evaporate ammonia. The resulting 
mixture was diluted with ether, filtered and concentrated in vacuo. The diol was dissolved in 
CH2Cl2 (80 mL).  PCC (8.62 g, 40 mmol) and Celite (8.62 g) were added, and the resulting 
solution was stirred for 48 h, and then filtered through a silica gel pad on a sintered-glass 
funnel.  The residue was purified by column chromatography on silica gel (EtOAc/hexane, 1: 
5) to furnish 167 (2.16 g, 74%): 1H NMR (300 MHz, CDCl3) δ 5.64-5.50 (m, 1H), 4.95-4.90 
(m, 2H), 3.67 (s, 3H), 2.55-2.05 (m, 6H), 1.64-1.49 (m, 2H), 1.32-1.23 (m, 1H), 1.11 (s, 3H), 
1.04 (s, 3H), 1.01 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 211.17, 208.42, 171.63, 136.61, 
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116.88, 64.92, 61.54, 52.02, 46.45, 43.71, 39.88, 39.74, 33.76, 23.45, 21.93, 17.43, 16.86; 
HRMS (EI) m/z calcd for 292.16746, found 292.16777. 
 
O
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7-Allyl-3-bromo-5,8,8-trimethyl-4,9-dioxobicyclo[3.3.1]non-2-ene-1-carboxylic acid 
methyl ester (175) 
To a stirred solution of KH (2 g, 30% in mineral oil, 15 mmol, mineral oil was 
removed with hexane washing prior to use) in THF (20 mL) were added a solution of 
compound 167 (1.46 g, 5 mmol) and triisopropylsilyl trifluoromethanesulfonate (2.7 mL, 10 
mmol) in THF (10 mL), and stirred for 12 h. The reaction mixture was diluted with saturated 
NaHCO3 (20 mL) and extracted with ethyl acetate (15 mL x 3). The combined organic phase 
was successively washed with water, brine, and then dried over anhydrous MgSO4. After 
solvent evaporation, the residue was purified by column chromatography on silica gel 
(EtOAc/hexane, 1: 30) to give the silylated compound. This compound was dissolved in CCl4 
(20 mL), followed by the addition of NBS (3.56 g, 10 mmol) and AIBN (82 mg, 0.5 mmol). 
The mixture was refluxed for 1 h. After being cooled to room temperature, it was diluted 
with aqueous NaHCO3 and extracted with CH2Cl2 (20 mL x 2). The combined organic layers 
were washed with brine and dried over anhydrous MgSO4. The residue was purified by 
column chromatography on silica gel (EtOAc/hexane, 1: 7) to furnish 175 (1.31 g, 71%): 1H 
NMR (300 MHz, CDCl3) δ 7.64 (s, 1H), 5.67-5.53 (m, 1H), 5.04-4.98 (m, 2H), 3.80 (s, 3H), 
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2.31-2.25 (m, 1H), 2.02-1.96 (m, 1H), 1.74-1.63 (m, 2H), 1.51-1.41 (m, 1H), 1.31 (s, 3H), 
1.20 (s, 3H), 1.17 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 201.65, 191.52, 167.60, 146.37, 
136.14, 125.47, 117.66, 71.12, 63.17, 52.99, 44.95, 42.03, 40.41, 34.02, 24.09, 16.69, 16.62; 
HRMS (EI) m/z calcd for 368.06232, found 368.06285. 
 
O
CO2Me
O
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7-Allyl-3-[3-(tert-butyldimethylsilanyloxy)-3-methylbut-1-ynyl]-5,8,8-trimethyl-4,9-
dioxobicyclo[3.3.1]non-2-ene-1-carboxylic acid methyl ester (177) 
In a 20 mL round-bottomed flask were placed 167 (112.5 mg, 0.304 mmol), 
bis(triphenylphosphine)palladium dichloride (4.2 mg, 2 mol%), and copper(I) iodide (3 mg, 5 
mol%) under an argon atmosphere. To this mixture were added diethylamine (5 mL) and 
tert-butyl-(1,1-dimethylprop-2-ynyloxy)dimethylsilane (121 mg, 0.608 mmol), and the 
resulting mixture was heated to reflux for 24 h. Excess diethylamine was evaporated under 
reduced pressure, and the residue was dissolved in ether (15 mL), and the insoluble material 
was filtered off. The ethereal solution was washed successively with brine, 10% HCl, water, 
sat. sodium bicarbonate, and finally brine, dried over anhydrous MgSO4. The residue was 
purified by column chromatography on silica gel (EtOAc/hexane, 1: 10) to give 177 (103.5 
mg, 70%): 1H NMR (400 MHz, CDCl3) δ 7.34 (s, 1H), 5.64-5.55 (m, 1H), 5.03-4.98 (m, 2H), 
3.79 (s, 3H), 2.30-2.25 (m, 1H), 1.98 (dd, J = 13.6, 4.0 Hz, 1H), 1.77-1.63 (m, 2H), 1.54 (s, 
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3H), 1.53 (s, 3H), 1.47 (t, J = 6.8 Hz, 1H), 1.27 (s, 3H), 1.20 (s, 3H), 1.16 (s, 3H), 0.87 (s, 
9H), 0.18 (s, 6H). 
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CHAPTER 2.  DIRECT SYNTHESES OF 7,8-DIHYDROXYCALAMENENE 
AND MANSONONE C 
 
Introduction 
Allylic 1,3-strain has been used in acyclic systems to direct the introduction of new 
stereogenic centers.1  The rotation of any alkyl group relative to a double bond is an 
important conformational event.  This becomes even more interesting, when there is a 
substituent on the double bond Z to the allylic center, such as compound a (Figure 1).  Indeed, 
conformation b is significantly destabilized by allylic 1,3-strain that represents a maximum 
energy determining the rotational barrier.2  Thus, the conformer equilibrium strongly favors 
conformation a in order to avoid allylic 1,3-strain.   
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Figure 1. Rotamers of (2Z)-4-methylpent-2-ene 
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Notable examples include diastereoselective epoxidations by Kishi3 and Adam,4 and 
acyclic stereoselective radical reactions by Giese.5  The epoxidation of c using MCPBA 
yielded d as a single diastereomer (Scheme 1).  Because the eclipsed conformations c2 and 
c3 have steric compression by allylic 1,3-strain, only conformer c1 could participate in the 
oxidation event.  The cooperative effect of the hydroxy group and the ether oxygen also 
direct the course of the epoxidizing reagent.6      
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Scheme 1 
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Despite its wide use as useful synthetic tool to direct the stereoselectivity, we are not 
aware of any application of the allylic 1,3-strain concept to control the relative 
stereochemistry in disubstituted tetralins.  Tetralins, such as 1, 3 and 4, have attracted 
considerable synthetic attention.7  7,8-Dihydroxycalamenene (1a) exhibits useful anti-
infective activity.8  Hydroxycalamenene (1b) was isolated from Hypericum elodeoides.9  
Mansonone C (2), extracted from the heartwood of Mansonia altissima,10 was found to 
possess promising antifungal, larvicidal and antioxidant properties.11  7-
Hydroxyerogorgiaene (3) and elisapterosin B (4) were isolated from the West Indian 
gorgonian octocoral Pseudopterogorgia elisabethae, and 3 was found to induce 77% growth 
inhibition for Mycobacterium tuberculosis H37Rv at a concentration of 6.25 μg/mL.7            
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Figure 2. Tetralin-derived products and Mansonone C 
 
In 1993, Schmalz and co-workers reported a synthesis of 1a using arene-chromium 
complexes to introduce the relative stereochemistry (Scheme 2).12  The synthesis commenced 
with the reaction of 4-(2,3-dimethoxyphenyl)butyric acid (5) and diazomethane, followed by 
cyclization using sulfuric acid, to obtain tetralone 6.  Enantiomerically pure alcohol 7 was 
prepared from 6 via borane reduction in the presence of a D-proline-derived oxazaboroline 
catalyst, followed by recrystalization using EtOAc/hexane.  Diastereoselective complexation 
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of 7 with Cr(CO)6 leading to 8 was accomplished.  The Cr(CO)6 group serves two purposes 
as follow:  (1) enhance the activity at the benzylic position, thus allowing alkylations under 
mild conditions, and (2) also guarantee the cis-configuration of the benzylic substituent by 
sterically blocking one π-face of the arene.  Benzylic dehydration, followed by protection of 
the acidic ortho-methoxy aryl position of 9 as a TMS group, gave 10.   
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Scheme 2 
  
 Benzylic methylation of 10 employing n-BuLi in THF/HMPA and methyl iodide 
followed by iso-propylation was accomplished to furnish stereoselective cis-disubstituted 
compound 12 as the sole product.  Desilylation, ortho-methylation and oxidative 
decomplexation using iodine gave 14.  Deprotection of the methyl ether group by BBr3 
completed the synthesis of 7,8-dihydroxycalamenene (1a).    
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Many synthetic approaches to these compounds begin with natural products, such as 
menthone, wherein the relative stereochemistry has already been established.13  Several 
researchers have noted that attempts to install stereochemistry by epimerization or by 
cyclization onto the aromatic ring have led to mixtures.14,15 
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In this study, we exploited a direct, efficient synthetic route to 7,8-
dihydroxycalamenene (1a) employing the concept of allylic 1,3-strain to direct the relative 
stereoselectivity.  Under the condition of TFA/HOAc, the system such as 15, wherein allylic 
strain between G and the methyl group forces the methyl group to be axial as the six-
membered ring is being formed, would afford the cis-stereoisomer 17. 
 
Results and Discussion 
In order to evaluate the directing effect, we first synthesized allylic acetate 22 
(Scheme 5).  The synthesis of allylic acetate 22 was achieved starting from the commercially 
available 2-bromo-1,4-dimethoxybenzene (18).  Metal-halogen exchange of 18, followed by 
the addition of 6-methyl-5-hepten-2-one at low temperature, produced the adduct 19.  
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Scheme 6 
Dehydration of the resulting benzylic alcohol using Li/NH3 furnished 20.  Allylic 
oxidation of 20 by the method of Sharpless16 yielded an allylic alcohol 21, which, upon 
acetylation, afforded 22. The attempted cyclization of allylic acetate 22 using the conditions 
of Ma and Zheng17 afforded tetralin 24 as a single diastereomer in a 51% yield, without any 
evidence of generating compound 23, the expected product (Scheme 6). To our surprise, the 
reaction also produced naphthalene 25 in a 37% yield. We believe that the formation of 24 
and 25 result from a novel cation-mediated disproportionation reaction (Scheme 7). 
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Accordingly, in situ generated cationic intermediate 22b was reduced by the isomeric 
intermediate 22c to give 24, whereas 22c, in turn, oxidized to form the aromatized product 25. 
Comparison of the 1H NMR spectrum of 24 with that of the literature compound13 showed 
that the cis-stereoisomer was exclusively formed.  
TFA
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Me Me
Me
Me Me
28 (39%)
+
70 oC, 12 h
Me
OAc
Me
26 27 (51%, dr = 1.3:1)  
Scheme 8 
In support of this allylic 1,3-strain assisted stereoselective cyclization, we have found 
that cyclization of allylic acetate 26, which does not contain the directing group G, affords 
tetralin 27 as a 1.3:1 mixture of diastereomers (Scheme 8).  Furthermore, the oxidation 
product 28 was also isolated in a 39% yield. 
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With the stereochemistry of 24 established, we began the synthesis of 1a by the 
reaction of the readily available 5-methyl-4-hexen-1-al18 with the ortho-lithiated 1,2-
bis(methoxymethoxy)-3-methylbenzene (Scheme 9).  The resulting alkoxide was in situ 
acetylated by the addition of acetic anhydride.  The displacement of  the acetate to the 
corresponding methyl group was achieved using Me3Al to afford 31.  In order to enhance the 
stability for the acid-mediated cyclization, the MOM protecting groups were converted to 
more stable methyl ether 33. It was then oxidized and acetylated employing the same 
methods used to generate 22. 
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Cyclization of 34 using trifluoroacetic acid in acetic acid at 70 °C for 12 hours 
provided an inseparable mixture of 35 and 36 (Scheme 10).  Subsequent deprotection of the 
mixture of 35 and 36 using  BBr3 generated 7,8-dihydroxycalamenene (1a).  Interestingly, 
the diol 36a was not obtained.  Instead, it underwent further oxidation under the reaction 
conditions to furnish mansonone C (2), a potent antifungal agent. 
The direct synthesis of 7,8-dihydroxycalamenene (1a) demonstrates the successful 
application of allylic strain in the stereoselective synthesis.  We are currently applying this 
synthetic strategy to the synthesis of analog natural products. 
 
Experimental 
Unless otherwise noted, materials were obtained from commercial suppliers and used 
without purification.  Tetrahydrofuran and diethyl ether were distilled from sodium and 
benzophenone.  Dichloromethane, benzene and diisopropylamine were distilled over calcium 
hydride.  All experiments were performed under an argon atmosphere unless otherwise noted.  
Organic extracts were dried over anhydrous magnesium sulfate.  Nuclear magnetic resonance 
experiments were performed with a Bruker 400 MHz instrument.  All chemical shifts are 
reported relative to CDCl3 (7.27 ppm for 1H and 77.23 ppm for 13C), unless otherwise noted.  
Coupling constants (J) are reported in Hz with abbreviations: s = singlet, d = doublet, t = 
triplet, q = quartet, m = multiplet.  High resolution mass spectra were recorded on a Kratos 
model MS-50 spectrometer.  Standard grade silica gel (60 Å, 32-63 μm) was used for flash 
column chromatography. 
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2-(2,5-Dimethoxyphenyl)-6-methylhept-5-en-2-ol (19) 
To a cooled (-78 oC), stirred solution of 1-bromo-2,5-dimethoxybenzene (1.17 g, 10 
mmol) in THF (10 mL) was added n-BuLi (4.4 mL of 2.5 M solution in hexane, 11 mmol). 
The mixture was stirred for 30 min, and then 6-methyl-5-hepten-2-one (1.26 g, 10 mmol) in 
THF (5 mL) was added. The resulting mixture was slowly warmed to room temperature, 
which was then poured into saturated brine. This was extracted with ether (10 mL x 3). The 
combined organic layers were dried over anhydrous MgSO4 and concentrated in vacuo. The 
residue was purified by column chromatography on silica gel (EtOAc/hexane, 1:6) to afford 
the title compound (2.25 g, 85%): 1H NMR (400 MHz, CDCl3) δ 6.92 (d, J = 2.8 Hz, 1H), 
6.84 (d, J = 8.8 Hz, 1H), 6.75 (dd, J = 8.8, 2.8 Hz, 1H), 5.11-5.07 (m, 1H), 3.85 (s, 3H), 3.78 
(s, 3H), 2.04-1.81 (m, 4H), 1.66 (s, 3H), 1.52 (s, 3H), 1.53 (s, 3H); 13C NMR (100 MHz, 
CDCl3) δ 153.69, 151.08, 136.29, 131.63, 124.66, 114.04, 112.14, 111.47, 75.21, 55.92, 
55.77, 42.08, 27.46, 25.83, 23.48, 17.71; HRMS (EI) m/z calcd for 264.17254, found 
264.17286. 
 
O
O  
2-(1,5-Dimethylhex-4-enyl)-1,4-dimethoxybenzene (20) 
In a 100 mL, 2-necked, round-bottomed flask fitted with a stirrer, and dry ice 
condenser were placed 2-(2,5-dimethoxyphenyl)-6-methylhept-5-en-2-ol (1.6 g, 6 mmol), t-
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BuOH (1.1 g, 15 mmol), and dry THF (10 mL). To the cooled (-78 oC), stirred solution 30 
mL of ammonia (NH3) was collected and then freshly cut sodium (0.35 g, 15 mmol) was 
added over 3-5 min. The resulting mixture was further stirred until all the sodium was 
consumed, as evidenced by the conversion of the colors to white, and NH4Cl powder (1 g) 
was added. The temperature of the bath was allowed to rise gradually to room temperature 
and the reaction was stirred overnight to evaporate ammonia. The resulting mixture was 
filtered and concentrated in vacuo. After purification by column chromatography 
(EtOAc/hexane, 1:20), the title compound (1.36 g, 91%) was isolated: 1H NMR (400 MHz, 
CDCl3) δ 6.78 (d, J = 8.8 Hz, 1H), 6.77 (d, J = 2.8 Hz, 1H), 6.68 (dd, J = 8.8, 2.8 Hz, 1H), 
5.14-5.10 (m, 1H), 3.78 (s, 6H), 3.19-3.14 (m, 1H), 1.96-1.88 (m, 2H), 1.68 (s, 3H), 1.65-
1.50 (m, 5H), 1.19 (d, J=7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 153.86, 151.55, 137.47, 
131.25, 124.91, 113.70, 111.56, 110.20, 56.18, 55.67, 37.32, 31.97, 26.39, 25.88, 21.20, 
17.74; HRMS (EI) m/z calcd for 248.17763, found 248.17789. 
 
General procedure for allylic oxidation 
In a 100 mL round-bottomed flask, SeO2 (0.5 mmol) was dispersed in CH2Cl2 (25 
mL). t-BuO2H (70% in water, 11 mmol) was added dropwise, and the mixture was stirred at 
room temperature for 10 min. After that time, the mixture was cooled to 0 °C, and then the 
dimethoxybenzene (5 mmol) in CH2Cl2 (10 mL) was slowly added. The reaction was stirred 
for 36 h, after which time it was poured into NaOH (10% aq.) and extracted with 
dichloromethane. The organic extracts were washed with water, and then with brine. The 
solvent was dried over MgSO4, the solids were filtered, and the mixture was then 
concentrated on a rotary evaporator. The crude was dissolved in methanol (10 mL) and 
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cooled to 0 °C, and NaBH4 (5.5 mmol) was added to reduce the aldehyde by-product. After 1 
h, the mixture was poured into water, extracted with ether and then washed with brine. The 
organic extract was dried over MgSO4 and concentrated in vacuo. After evaporation, the 
residue was purified by column chromatography on silica gel to give the allylic alcohols (69-
71%). 
 
O
O
OH  
(2E)-6-(2,5-Dimethoxyphenyl)-2-methylhept-2-en-1-ol (21) 
1H NMR (400 MHz, CDCl3) δ 6.79 (d, J = 8.8 Hz, 1H), 6.76 (d, J = 3.2 Hz, 1H), 6.67 
(dd, J = 8.8, 3.2 Hz, 1H), 5.38 (t, J = 7.3 Hz, 1H), 3.96 (d, J = 6.0 Hz, 2H), 3.78 (s, 6H), 
3.21-3.15 (m, 1H), 2.02-1.94 (m, 2H), 1.71-1.57 (m, 5H), 1.19 (d, J=7.2 Hz, 3H); 13C NMR 
(100 MHz, CDCl3) δ 153.85, 151.54, 137.25, 134.74, 126.71, 113.78, 111.72, 110.27, 69.22, 
56.34, 55.78, 36.82, 31.86, 25.91, 21.34, 13.75; HRMS (EI) m/z calcd for 264.17254, found 
264.17286. 
 
General procedure for acetylation 
To a cooled (0 oC), stirred solution of alcohol (10 mmol) in CH2Cl2 (30 mL) was 
added acetic anhydride (20 mmol) and DMAP (20 mmol). The mixture was stirred for 3 h, 
and then diluted with aq. NH4Cl. This was extracted with ether (80 mL x 2). The combined 
organic layers were dried over anhydrous MgSO4 and concentrated in vacuo. The residue 
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was purified by column chromatography on silica gel to furnish acetylated compounds (80-
91%). 
O
O
OAc  
(2E)-6-(2,5-Dimethoxyphenyl)-2-methylhept-2-enyl acetate (22) 
1H NMR (400 MHz, CDCl3) δ 6.79 (d, J=8.8 Hz, 1H), 6.76 (d, J=3.2 Hz, 1H), 6.70 
(dd, J=8.8, 3.2 Hz, 1H), 5.46 (t, J=6.8 Hz,1H), 4.44 (s, 2H), 3.78 (s, 6H), 3.20-3.14 (m, 1H), 
2.07 (s, 2H), 2.06-1.94 (m, 2H), 1.73-1.54 (m, 5H), 1.20 (d, J=7.2 Hz, 3H); 13C NMR (100 
MHz, CDCl3) δ 171.12, 153.81, 151.50, 137.01, 130.15, 129.91, 113.71, 111.53, 110.26, 
70.52, 56.20, 55.72, 36.70, 31.91, 26.04, 21.17, 21.12, 14.01; HRMS (EI) m/z calcd for 
306.18311, found 306.18346. 
 
General procedure for cyclization 
The allylic acetate (0.5 mmol) in 1 mL of TFA/HOAc (v/v = 3:1) was stirred at 70 oC 
for 12 h. The reaction mixture was quenched with saturated aq NaCl (10 mL) and extracted 
with ether (15 mL x 3). The combined organic phases were successively washed with water, 
saturated NaHCO3, and dried over MgSO4, which was then concentrated in vacuo. 
 
O
O  
1-Isopropyl-5,8-dimethoxy-4-methyl-1,2,3,4-tetrahydronaphthalene (24) 
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Purification by column chromatography on silica gel gave the compound 24 in 51% 
yield: 1H NMR (400 MHz, CDCl3) δ 6.66 (s, 2H), 3.81 (s, 3H), 3.77 (s, 3H), 3.22-3.17 (m, 
1H), 3.03-2.98 (m, 1H), 2.36-2.28 (m, 1H), 1.86-1.75 (m, 2H), 1.65-1.54 (m, 2H), 1.27 (d, J 
= 7.2 Hz, 3H), 0.95 (d, J = 6.8 Hz, 3H), 0.78 (d, J = 6.8 Hz, 3H); 13C NMR (100 MHz, 
CDCl3) δ 151.93, 151.67, 133.32, 131.82, 107.38, 107.17, 55.65, 55.62, 38.48, 30.12, 27.71, 
27.26, 21.36, 21.27, 21.15, 18.97; HRMS (EI) m/z calcd for 248.17763, found 248.17803. 
 
O
O  
1-Isopropyl-5,8-dimethoxy-4-methylnaphthalene (25) 
Purification by column chromatography on silica gel gave the compound 25 in 37% 
yield: 1H NMR (400 MHz, CDCl3) δ 7.94 (s, 1H), 7.16 (s, 1H), 6.71-6.66 (m, 2H), 3.97 (s, 
3H), 3.88 (s, 3H), 3.08-2.99 (m, 1H), 2.90 (s, 3H), 1.35 (d, J = 6.8 Hz, 6H); 13C NMR (100 
MHz, CDCl3) δ 152.44, 149.68, 146.04, 135.13, 129.08, 128.04, 124.66, 116.31, 104.23, 
103.51, 56.00, 55.96, 34.41, 25.33, 24.15; HRMS (EI) m/z calcd for 244.14633, found 
244.14671. 
 
 
1-Isopropyl-4-methyl-1,2,3,4-tetrahydronaphthalene (27) 
Purification by column chromatography on silica gel gave the compound 27 in 51% 
yield  as a 1.3:1 mixture of diastereomers: 1H NMR (400 MHz, CDCl3) δ 7.26-7.11 (m, 4H), 
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2.94-2.92 (m, 0.6H), 2.85-2.80 (m, 0.4H), 2.77-2.72 (m, 0.5H), 2.68-2.63 (m, 0.6H), 2.32-
2.21 (m, 1H), 2.03-1.96 (m, 0.5H), 1.90-1.58 (m, 3H), 1.43-1.36 (m, 0.5H), 1.30 (d, J = 7.2 
Hz, 1.7H), 1.29 (d, J = 7.2 Hz, 1.3H), 1.05 (d, J = 6.8 Hz, 1.7H), 1.02 (d, J = 6.8 Hz, 1.3H), 
0.78 (d, J = 6.8 Hz, 1.7H), 0.73 (d, J = 7.2 Hz, 1.3H); HRMS (EI) m/z calcd for 188.15650, 
found 188.15684. 
 
 
1-Isopropyl-4-methylnaphthalene (28) 
Purification by column chromatography on silica gel gave the compound 28 in 39% 
yield: 1H NMR (400 MHz, CDCl3) δ 8.20-8.17 (m, 1H), 8.07-8.03 (m, 1H), 7.57-7.52 (m, 
2H), 7.33 (d, J = 3.6 Hz, 2H), 3.80-3.73 (m, 1H), 2.70 (s, 3H), 1.42 (d, J = 6.8 Hz, 6H); 13C 
NMR (100 MHz, CDCl3) δ 133.10, 132.24, 131.56, 126.64, 125.51, 125.29, 125.13, 124.00, 
121.55, 28.57, 23.85, 19.74; HRMS (EI) m/z calcd for 184.12520, found 184.12540. 
 
OMOMOAc
OMOM
 
1-[2,3-Bis(methoxymethoxy)-4-methylphenyl]-5-methylhex-4-enyl acetate (30) 
To a solution of 1,2-bis(methoxymethoxy)-3-methylbenzene (4.3 g, 20 mmol) in dry 
THF (80 mL) was added n-BuLi (8.4 mL of 2.5 M solution in hexane, 21 mmol) at 0 oC. The 
mixture was stirred for 2 h at room temperature. The mixture was cooled to -78 oC, and then 
5-methyl-4-hexen-1-al (2.5 g, 22 mmol) in THF (10 mL) was added. The reaction was stirred 
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for an additional 1 h at -78 oC, and then slowly warmed to room temperature. The resulting 
mixture was then cooled to 0 oC and acetic anhydride (2.1 mL, 22 mmol) was added. The 
mixture was stirred for 1 h, and then diluted with brine (100 mL) and extracted with ether. 
The combined organic layers were dried over MgSO4, filtered and concentrated under 
reduced pressure. Flash chromatography on silica gel (EtOAc/hexane, 1:4) yielded the title 
compound (5 g, 77%): 1H NMR (400 MHz, CDCl3) δ 7.07 (d, J = 8.0 Hz, 1H), 6.97 (d, J = 
8.0 Hz, 1H), 5.19-5.04 (m, 5H), 4.97-4.92 (m, 1H), 3.60 (s, 3H), 3.57 (s, 3H), 2.78 (d, J = 4.0 
Hz, 1H), 2.31 (s, 3H), 2.17-2.08 (m, 2H), 1.97-1.88 (m, 1H), 1.83-1.76 (m, 1H), 1.70 (s, 3H), 
1.61 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 148.27, 148.19, 136.89, 132.18, 132.14, 126.86, 
124.25, 122.10, 99.79, 99.21, 68.14, 57.80, 57.79, 36.61, 25.94, 25.07, 17.88, 16.67; HRMS 
(EI) m/z calcd for 324.19367, found 324.19405. 
 
OMOM
OMOM
 
1-(1,5-Dimethylhex-4-enyl)-2,3-bis(methoxymethoxy)-4-methylbenzene (31) 
To a solution of 1-[(2,3-bis(methoxymethoxy)-4-methylphenyl]-5-methylhex-4-enyl 
acetate (2.2 g, 6 mmol) in CH2C12 (30 mL) was added trimethylaluminum (9.0 mL of 2.0 M 
solution in hexane, 18 mmol) at -78 oC under argon. The reaction mixture was warmed to 0 
oC over 3 h, quenched with water, and extracted with ether. The organic layer was washed 
with saturated aq. NaHCO3, and brine, dried over MgSO4, and evaporated under reduced 
pressure. The residue was chromatographed on silica gel (EtOAc/hexane, 1:20) to afford the 
title compound (31) (1.7 g, 88%): 1H NMR (400 MHz, CDCl3) δ 6.92 (d, J = 8.0 Hz, 1H), 
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6.89 (d, J = 8.0 Hz, 1H), 5.13-5.02 (m, 5H), 3.59 (s, 6H), 3.25-3.19 (m, 1H), 2.29 (s, 3H), 
2.02-1.83 (m, 2H), 1.76-1.55 (m, 8H), 1.19 (d, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) 
δ 148.50, 147.60, 140.06, 129.90, 126.91, 126.49, 124.79, 121.92, 99.50, 99.29, 57.74, 57.68, 
38.04, 31.39, 26.43, 25.87, 22.00, 17.80, 16.57; HRMS (EI) m/z calcd for 322.21441, found 
322.21491. 
 
OH
OH
 
3-(1,5-Dimethylhex-4-enyl)-6-methylbenzene-1,2-diol (32) 
To a slution of 1-(1,5-dimethylhex-4-enyl)-2,3-bis(methoxymethoxy)-4-
methylbenzene (161 mg, 0.5 mmol) in i-PrOH (1.6 mL) was added AcCl (0.18 mL, 2.5 
mmol) at 0 oC. The reaction was monitored by TLC to avoid prolonged reaction times. After 
completion (5 h), H2O (15 mL) was added and the mixture was extracted with EtOAc (3 x 20 
mL). The combined organic phases were washed with H2O and concentrated to afford a 
quantitative yield of the title compound, which were used for the next step without further 
purification: 1H NMR (400 MHz, CDCl3) δ 6.71 (d, J = 8.0 Hz, 1H), 6.67 (d, J = 8.0 Hz, 1H), 
5.25-5.17 (m, 3H), 3.01-2.95 (m, 1H), 2.25 (s, 3H), 1.99-1.94 (m, 2H), 1.73 (s, 3H), 1.70-
1.63 (m, 2H), 1.57 (s, 3H), 1.27 (d, J=7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 142.07, 
141.12, 132.74, 131.24, 124.97, 122.43, 121.31, 117.92, 37.59, 31.73, 26.16, 25.94, 21.41, 
17.94, 15.57; HRMS (EI) m/z calcd for 262.19328, found 262.19376. 
 
 102
O
O
 
1-(1,5-Dimethylhex-4-enyl)-2,3-dimethoxy-4-methylbenzene (33) 
To a slution of 3-(1,5-dimethylhex-4-enyl)-6-methylbenzene-1,2-diol (117 mg, 0.5 
mmol) in DMF (3 mL) was added NaH (60 mg of 60% dispersed in mineral oil, 1.5 mmol), 
and the solution was stirred at room temperature for 30 min, after which MeI (213 mg, 1.5 
mmol) was added and the reaction was stirred overnight. It was then diluted with aq. NH4Cl. 
This was extracted with ether (10 mL x 2). The combined organic layers were dried over 
anhydrous MgSO4 and concentrated in vacuo. The residue was purified by column 
chromatography on silica gel to furnish the title compound (33) (125 mg, 95%): 1H NMR 
(400 MHz, CDCl3) δ 6.71 (d, J = 8.0 Hz, 1H), 6.67 (d, J = 8.0 Hz, 1H), 5.25-5.17 (m, 3H), 
3.01-2.95 (m, 1H), 2.25 (s, 3H), 1.99-1.94 (m, 2H), 1.73 (s, 3H), 1.70-1.63 (m, 2H), 1.57 (s, 
3H), 1.27 (d, J=7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 142.07, 141.12, 132.74, 131.24, 
124.97, 122.43, 121.31, 117.92, 37.59, 31.73, 26.16, 25.94, 21.41, 17.94, 15.57; HRMS (EI) 
m/z calcd for 262.19328, found 262.19376. 
 
O
OH
O
 
(2E)-6-(2,3-Dimethoxy-4-methylphenyl)-2-methylhept-2-en-1-ol 
1H NMR (400 MHz, CDCl3) δ 6.89 (d, J = 8.0 Hz, 1H), 6.83 (d, J = 8.0 Hz, 1H), 5.39 
(t, J = 7.2 Hz, 1H), 4.01 (s, 2H), 3.84 (s, 3H), 3.83 (s, 3H), 3.20-3.11 (m, 1H), 2.25 (s, 3H), 
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2.05-1.89 (m, 2H), 1.71-1.58 (m, 2H), 1.56 (s, 3H), 1.20 (d, J=6.8 Hz, 3H); 13C NMR (100 
MHz, CDCl3) δ 151.40, 150.87, 139.05, 134.86, 129.62, 126.68, 125.87, 121.62, 69.25, 
60.90, 60.09, 37.36, 31.64, 26.04, 22.48, 15.86, 13.82; HRMS (EI) m/z calcd for 278.18819, 
found 278.18867. 
O
OAc
O
 
(2E)-6-(2,3-Dimethoxy-4-methylphenyl)-2-methylhept-2-enyl acetate (34) 
1H NMR (400 MHz, CDCl3) δ 6.88 (d, J = 8.0 Hz, 1H), 6.83 (d, J = 8.0 Hz, 1H), 5.47 
(t, J = 7.2 Hz, 1H), 4.44 (s, 2H), 3.84 (s, 3H), 3.83 (s, 3H), 3.17-3.12 (m, 1H), 2.25 (s, 3H), 
2.07 (s, 3H), 2.06-1.91 (m, 2H), 1.70-1.55 (m, 5H), 1.21 (d, J=7.2 Hz, 3H); 13C NMR (100 
MHz, CDCl3) δ 171.10, 151.39, 150.92, 138.95, 130.05, 130.00, 129.62, 125.78, 121.51, 
70.48, 60.76, 60.01, 37.32, 31.83, 26.24, 22.15, 21.16, 15.82, 14.06; HRMS (EI) m/z calcd 
for 320.19876, found 320.19919. 
 
Procedure for demethylation  
After the cyclization of 17,  allylic acetate (0.5 mmol) in 1 mL of TFA/HOAc (v/v = 
3:1) was stirred at 70 oC for 12 h. The reaction mixture was quenched with saturated NaCl 
(10 mL) and extracted with ether (15 mL x 3). The combined organic phase was successively 
washed with water, saturated NaHCO3, and dried over MgSO4. After evaporation, the residue 
was dissolved in CH2Cl2 and cooled to -78 oC with stirring. To this solution, BBr3 (1 M 
solution in CH2Cl2, 1 mmol) was added and stirred for 1 h. Meanwhile, the reaction mixture 
was slowly warmed to room temperature. After this, aq. 10% NaOH solution (2 mL) was 
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added. The resulting hydrolyzed mixture was then acidified with aq. 10% HCl and extracted 
with ether. The combined organic layers were dried over anhydrous MgSO4 and concentrated 
in vacuo. 
OH
OH
 
7,8-Dihydroxycalamenene (1a) 
Purification by column chromatography on silica gel gave compound 1a in two steps 
in a 30% yield: 1H NMR (400 MHz, CDCl3) δ 6.64 (s, 1H), 5.09 (s, 1H), 4.74 (s, 1H), 3.08-
3.04 (m, 1H), 2.68-2.62 (m, 1H), 2.39-2.32 (m, 1H), 2.23 (s, 3H),1.78-1.61 (m, 4H), 1.26 (d, 
J = 7.2 Hz, 3H), 1.04 (d, J = 6.8 Hz, 3H), 0.67 (d, J = 6.8 Hz, 3H); 13C NMR (100 MHz, 
CDCl3) δ 141.04, 139.04, 132.37, 127.84, 121.26, 121.00, 42.95, 30.87, 29.02, 27.22, 21.25, 
20.72, 17.52, 16.54, 15.87; HRMS (EI) m/z calcd for 234.16198, found 234.16227. 
 
O
O
 
Mansonone C (2) 
Purification by column chromatography on silica gel gave mansonone C (2) in two 
steps and 46% yield as an orange solid: mp 134–137 oC; 1H NMR (400 MHz, CDCl3) δ 7.66 
(s, 1H), 7.44 (d, J = 8.0 Hz, 1H), 7.20 (d, J = 8.0 Hz, 1H), 3.43-3.36 (m, 1H), 2.64 (s, 3H), 
2.09 (s, 3H), 1.30 (d, J = 6.8 Hz, 6H); 13C NMR (100 MHz, CDCl3) δ 182.49, 182.18, 145.51, 
143.24, 138.23, 135.18, 134.34, 132.63, 132.16, 129.46, 28.49, 23.97, 23.13, 16.25; HRMS 
(EI) m/z calcd for 228.11503, found 228.11537. 
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(2E)-6-(2,5-Dimethoxyphenyl)-2-methylhept-2-enyl acetate (22) 
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1-Isopropyl-5,8-dimethoxy-4-methyl-1,2,3,4-tetrahydronaphthalene (24) 
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1-Isopropyl-5,8-dimethoxy-4-methylnaphthalene (25) 
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1-Isopropyl-4-methyl-1,2,3,4-tetrahydronaphthalene (27) 
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1-Isopropyl-4-methylnaphthalene (28) 
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(2E)-6-(2,3-Dimethoxy-4-methylphenyl)-2-methylhept-2-enyl acetate (34) 
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7,8-Dihydroxycalamenene (1a) 
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Mansonone C (2) 
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GENERAL CONCLUSIONS 
 
In this dissertation, we have investigated the direct and efficient synthetic route to 
biologically active natural products. 
Chapter 1 describes a concise and efficient synthetic route to the highly funtionalized 
tricyclic core skeleton of papuaforin B.  In the course of the synthesis, an efficient cyclization 
method using Na/NH3 was demonstrated.  Newly developed bromination method leading to 
an α-bromoenone would serve as a handle for construction of the fused pyran ring of 
papuaforin B.  Further efforts along this line are in progress.  
Chapter 2 describes the direct synthesis of 7,8-dihydroxycalamenene, which includes 
the successful application of allylic strain in the stereoselective synthesis.  Interestingly, 
Mansonone C, a potent antifungal agent, was also obtained as the co-product from the same 
starting material.  Application of this synthetic strategy to the synthesis of analog natural 
products is in progress. 
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